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ABSTRACT OF THESIS

INFLUENCE OF DIETARY SELENIUM SUPPLEMENTATION FORM ON
HEPATIC TRANSCRIPTOME PROFILES OF MATURING BEEF HEIFERS
Our objective was to know how the hepatic transcriptome expression of
growing beef (Angus-cross) heifers (0.5 kg gain/day) was affected by the feeding of
different sources of dietary (3 mg/day) Se supplements: inorganic Se (ISe, sodium
selenite), organic (OSe, Sel-Plex®), or a blend (1.5 mg:1.5 mg) of ISe:OSe (Mix),
compared to the adequate but non-Se supplemented “Control”. The biopsied hepatic
tissues of these four groups heifers collected at day 168 (when liver Se assimilation
had stabilized) after supplements of Se, was subjected to the microarray analysis to
assess Se treatment effects.
The results suggest that there were clear differences in the hepatic gene
expression profile of the four Se treatment groups. 139 significantly treatmentinduced differentially expressed transcripts were selected. Among them: 1) the gene
expression profiles of Control and OSe appeared to be more similar than Control and
ISe, 2) eight distinct gene expression patterns among treatments were identified and
each of them indicates affected biofunctions and networks, 3) they were grouped as
the expression profile relative to Control, there were solely and commonly affected
transcripts for four Se treatments and they indicated different biofunctions, 4) of them,
three microRNAs were identified and their predicated mRNA targets showed different
biofunctions.
KEYWORDS: Bovine, Liver, Microarray, Biofunctions, MicroRNA
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Chapter 1: Introduction
As the largest segment of the American agricultural economy, the cattle
industry comprises approximately 1.23 million businesses with cattle, including beef
and dairy cattle. An estimated 1.064 million farmers and ranchers raise beef cattle in
the United States (Kentucky Beef Book, 1997). As one of the largest beef producing
states east of the Mississippi river, Kentucky is home to over 1.16 million beef cows
with a total cattle inventory of some 2.40 million head (Kentucky Beef Council, 2010).
Cattle producers generate more than $605 million dollars in cash sale receipts in 2007
(Kentucky Beef Council, 2010) According to recent data, beef cattle are produced on
45,000 (50.6 percent) of Kentucky’s 89,000 farms (Kentucky Beef Book, 1997).
Therefore, cattle production is very important to many farmers in Kentucky.
Se is a metalloid belonging to Group VIA of the Periodic Table, the same as
sulfur. Selenium plays an important role in regulation of various physiological
functions in beef cattle including immunity, reproduction and early postanatal
viability (Suzuki, 2005). Se deficiency alone, or in combination with vitamin E, is
associated with reduced growth and productivity rates (Surai, 2006), early mortality
(Surai, 2006) and immune-suppression (Surai, 2006). Se deficiency has been
specifically linked with the development of various diseases in ruminants (Pehrson,
1993; Kolb and Seehawer, 2001) including nutritional muscular dystrophy (white
muscle disease, the most well documented disease related to Se/vitamin E deficiency
in ruminants), retained placenta and metritis (affecting about 9% of USA dairy
industry births), and mastitis (estimated annual cost is $17,500 for a 100-cow herd)
(Surai, 2006).
The amount of Se available for the grazing beef cattle is dependent on Se
content of the forages (McDowell, 1996). The concentration and availability of Se in
1

the soil determines the Se content of forages and the Se requirement for beef cattle
among all ages is 0.10 mg Se/kg of diet (NRC, 2000). The Se content in forages (and
grains) of the southeast USA (including Kentucky) is low (＜ 0.05 mg Se/kg) to
variable (＜ 0.1 mg/kg) (Ammermann et al., 1975). Consistently, a survey of whole
blood Se concentrations of beef cows and heifers from 253 cow-calf operations in 18
states (Dargatz and Ross, 1996) found that 42% of southeastern USA (including
Kentucky) cattle were Se deficient (≤0.080μg/mL), as opposed to 18% nationally.
Therefore, dietary supplementation of Se is necessary in Kentucky.
Se supplementation is regulated by the Food and Drug Administration and
cannot exceed 120 mg Se/kg or an intake of 3 mg per day when delivered in freechoice mineral supplements to cattle (FDA, 1987). Se can be added to diets in either
inorganic or organic forms. Historically, the supplemental inorganic forms of Se
typically used are sodium selenite or sodium selenate (Brennan et al., 2011), despite
the knowledge that Se primarily is present in plants as organic forms. Organic forms
of Se include selenomethionine (SeMet) and selenocysteine (SeCys), which are
typically added to ruminant diets as constituents of Se-enrich yeast extracts (e.g.,
SeMet is the predominant form of Se in Sel-Plex® (Alltech Biotechnologies, Inc.,
Nicholasville, KY) (Korhola et al., 1986).
Even though they have different delivery speeds to liver (Kazuo and Suzuki,
2005), few differences in glutathionine peroxidase (GSH-Px) activities and Se
concentrations in blood and milk result from feeding selenite versus selenate to
heifers (Ortman et al., 1999). However, it may be reasonable to expect few
differences as selenate is probably converted to selenite in the rumen (Weiss, 2003).
The effect of supplementing diets with inorganic (ISe) versus organic (OSe)
forms of Se on Se bioavailability and bioactivity also has been compared.
2

Assimilation of Se after 105-106 days by whole blood, red blood cells, and biopsied
liver tissue was greater for heifers fed 3 mg/day of Se as Sel-Plex® versus sodium
selenite (Liao et al., 2011). Similarly, Se concentrations (219 to 257 µg/kg wet weight)
in the liver of cows supplemented with 3 mg/day as Se-yeast (Sel-Plex 50®) was 1.21.5 fold higher than with sodium selenite (Ortman and Pehrson, 1997). Thus, the
bioavailability (defined as blood and tissue Se concentrations) of Se from OSe sources
is higher than the ISe sources.
Regarding production responses to feeding OSe versus ISe, few studies have
found major differences between average daily gain, average daily feed intake, or gain:
feed ratios, or any other production performance parameter (Davis et al., 2008; Liao
2011; Nicholson, et al., 1991; Gunter et al., 2003). However, feeding organic forms of
Se to dams may have positive effects on their offspring. For example, feedlot steers
(Clyburn et al., 2007) and calves born from OSe-supplemented cows (Guyot et al.,
2006) tend to have better average daily gain compared to calves from ISe
supplemented cows. As for the Se biopotency (GSH-Px activity), different
experiments on beef cattle have demonstrated that supplementation of OSe (as Se
yeast) will increase blood Se GSH-Px versus ISe (sodium selenite) for weaned beef
steers (Fry et al., 2005; Gunter et al., 2003; Guyot, et al., 2007; Nicholson, et al.,
1991). This finding indicates that the Se biopotency is higher for beef cattle if dietary
OSe is supplemented versus ISe. Similarly, with regard to the animal responses under
stress condition including animal immunocompetence, OSe supplementation is
reported to induce higher states of immunocompetence than ISe, including increased
macrophage phagocytosis (Beck et al., 2005), higher production of antibodies in
response to antigen after infection (Nicholson et al., 1993), and decreased mean milk
somatic cell counts (Harrison et al., 2005). Such positive results in biopotency and
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immunocompetency with OSe versus ISe fed cattle, have led some to recommend that
OSe replace ISe forms of Se in cattle diets (Surai, 2006).
Recently a formulation of mixed (1:1) inorganic-organic Se supplements has
been used in beef cattle mineral mixes as the source of Se (University of Kentucky
Beef Cattle Mineral Mix). However, how this “mix” affects tissue Se assimilation and
metabolism relative to OSe or ISe Se sources is not known. To initiate such
comparisons, the diet of beef heifers was supplemented with none (Control) or 3.0 mg
Se/day as ISe, OSe (Sel-Plex®),or Mix (1.5 mg Se/day as ISe:1.5 mg Se/day as OSe)
for 224 days (Brennan et al., 2011). More Se was found in whole blood, red blood
cells, serum, and liver of Mix and OSe heifers than ISe heifers, and all Se
supplementation treatments resulted in greater Se assimilation than for nonsupplemented Control heifers. As stated by the authors, from a biochemical
perspective, the observed differences in steady-state Se assimilation by tissues
resulting from consumption of OSe versus ISe likely reflects the known common and
different metabolic fates of organic and inorganic Se forms and, by extension, may
provide insight into why consumption of a mix of 1.5 mg OSe and 1.5 mg of ISE
resulted in liver assimilation of Se that was equal to consumption of 3 mg/day of OSe
and greater than ISe (Brennan et al., 2011).
To better understand effects of different forms of Se supplementation of beef
cattle diets on whole-animal parameters and Se-specific metabolism, knowlege about
how the forms of supplemental Se may affect global gene expression profiles is
critical. However, with the exception of a pilot study by this research group (Liao et
al., 2010), no research has been conducted to determine the effect of dietary Se
supplementation on gene expression by beef cattle. The Liao et al. (2010) experiment
revealed that expression of about 80 genes by the liver of slow maturing beef heifers
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was altered by daily supplementation (105-106 days) of diets with 3 mg Se/day of ISe
or OSe versus non-suplemented, but Se adequate, cohorts. Because, however, only a
single time point was used in the experiment, it was not known if these differences
reflected stable or transient responses to forms of Se supplement.
To address this issue, and to determine the effect of a “mixed” Se supplement
consisting of 1:1 sodium selenite: Sel-Plex® (Mix), an expanded experiment (Brennan
et al., 2011) using the same animal model (maturing beef heifers and cottonseed hullbased diet) was conducted over a 224-day period using 3 mg Se/day dietary
supplement treatments (n=10) of ISe, Sel-Plex®, or Mix. Importantly, this study found
that liver Se concentrations were plateaued and stable after 112 days of
supplementation.

Thesis objective
Therefore, using day 168 liver tissue samples from this experiment (Brennan
et al., 2011) and microarray methodologies, the first objective was to test the
hypothesis that the hepatic transcriptome profiles identified in biopsied liver samples
from maturing beef heifers would be affected by the form of supplemental Se
consumed. The secondary objective was to conduct bioinformatic analyses of these
profiles to predict ostensible changes in physiological capacities induced by feeding
different forms of supplemental Se.

5

Chapter 2: Literature Review
Se specification
Selenium exists as inorganic and organic forms (Foster and Sumar, 1997). The
Se ion is conserved in minerals and soils (Underwood and Suttle, 2000). Plants
assimilate inorganic Se from soils and convert Se it into inorganic and organic forms
(Finley, 2005). Thus, the amount of Se contained in forages dictates the Se status of
grazing animals.
As mentioned in the Introduction, the Se requirement for beef cattle is 0.10 mg
Se/kg of diet (NRC, 2000). In Kentucky with its Se-deficient soils, the predominant
forage is tall fescue and the average Se content of tall fescue is 0.06 mg/kg (John et al.,
2003). Thus, Kentucky cattle typically consume Se-inadequate forages.
Plants can be divided into two groups with regard to Se. One is called “nonSe-accumulating”, and the major Se species in this group are selenate and SeMet, plus
smaller amounts of SeCys (Jacobs, 1989). The other group is known as “Seaccumulating”, and the predominant form of Se is γ-glutamyl methylSeCys (Shrift
and Virupaksha, 1965; Terry et al., 2000). From recent findings, the major forms of
Se available in feedstuffs for animals are SeMet and SeCys (Huerta et al., 2004).
SeMet is predominant in cereals (Fairweather-Tait et al., 2010). Many plants contain
plentiful SeMet because they have proteins that are high in sulfur-containing amino
acids, and SeMet can nonspecifically replace Met in binding to tRNAmet (FairweatherTait et al., 2010). SeMet also is the main Se compound in yeast and has been
identified after enzymatic digestion or acid hydrolysis (Gammelgaard et al., 2008).
Plants take up huge amounts of Se from the soil and transform it through
several biochemical steps into volatile species, a process called phytovolatilization
(Dumont et al., 2006). DMSe (Dimethyl Selenide) is the main phytovolatilization
6

product (Dumont et al., 2006). SeMet is favored for volatilization process, however,
SeCys is incorporated into proteins, hence, is no longer available for volatilization.
Inorganic Se from soils can be incorporated into the SeCys by plants (Ellis and Salt,
2003). After incorporation, the SeCys can be incorporated into Se-proteins. The
SeCys can also be metabolized into various non-proteinogenic Se amino acids
(Neuhierl et al., 1999). Their synthesis occurs along the S-pathway (Dumont et al.,
2006). Three metabolites: Se-MeSeCys, Se-Cystathionine and γ-glu-SeMeSeCys are
converted from the SeCys. The formation of Se-Cystathionine results in its
accumulation of it because the enzyme cystathionine β-lyase is unable to cleave this
Se analogue (Terry et al., 2000).
Se deficiency
It has been reported that Se deficiency is associated with physiological
discomfort and diseases in ruminant animals, including nutritional muscular
dystrophy and white muscle disease (the most well documented disease related to
Se/vitamin E deficiency in ruminants), retained placenta (retained fetal membranes)
and metritis (affecting about 9% of all calvings in US dairy industry births), mastitis
(costs $100-200/cow/year or about $17,500 annually for an average 100-cow herd),
unthriftiness and reduced growth rate, reduced reproduction rates,
immunosuppression and increased susceptibility to various disease, and sub-optimal
productivity and early mortality (Surai, 2006; Pehrson, 1993; Kolb and Seehawer,
2001). Thus, the maintenance of Se in an adequate level for the beef cattle is critical.
Se requirements for cattle
It is recommended that diets consumed by beef cattle at all stages of life
(calves, heifers and lactating and dry cattle) should be 0.10 mg Se/kg of diet, and that
7

the maximal amount of supplemental Se not exceed 3.0 mg Se per day (NRC, 2000).
The Se level in cattle has been classified as adequate, marginal and deficient when Se
level in plasma/serum were >75, 50-75 and <50 ng/ml; in whole blood >200; 140-200
and <140 ng/ml, in liver >1.25, 0.6-1.25 and < 0.5 ng/mg dry matter, respectively
(Smith et al., 1998; Zarski et al., 1998; Kincaid, 1999). During some specific periods
such as reproductive period, the requirement of Se is increased, thus the original Se
sources cannot meet the Se requirement of cattle and additional Se supplement is
necessary (Maus et al., 1980).

Se availability for cattle
The amount of Se available for grazing beef cattle is dependent on the forages
(FDA, 2007). As the plant Se is originally from inorganic Se in the soil, the
concentration and availability of Se in the soil determine the Se content of forages
(Hintze et al., 2001). For the areas where soil Se is deficient, beef cattle are more
easily subjected to Se deficiency. The geographic distribution of Se in forages and
grains, the southeast USA (including Kentucky) have low (80% of all forage and
grain contain < 0.05 mg Se/kg) to variable (50% of all forage and grain contain < 0.1
mg/kg) Se (Juniper et al., 2008). Forty-two percent of cattle in the southeastern United
States (including Kentucky) were Se deficient (≤ 0.080μg/mL) compared to 18% of
deficient animals nationally after testing whole blood Se concentrations of cattle and
heifers from 253 cattle-calf operations in 18 states (Dargatz and Ross, 1996). Thus,
the supplementation of Se for beef cattle is important in geographical areas where Se
is not adequately available for cattle, including Kentucky.
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Se supplementation
Mineral supplements for feedlot cattle are incorporated into their concentrate
diets. However, cattle grazing Se-deficient feedstuffs can receive mineral supplements
through a variety of delivery systems (Wichtel, 1998; Hemingway, 2003). These
include licks, drenching with Se compounds, intraruminal boluses, selenite or selenate
injections, depot injections, adding sodium selenite to the drinking water, various
methods of pasture and soil application, and by adding Se into feedstuffs (McDowell,
1996; Pavlata et al., 2001). Dietary Se supplements added in feedstuffs can be further
divided into organic and inorganic according to their chemical forms. Inorganic Se
supplements are frequently used and treated as an ordinary Se supplements for
ruminant (Azzi et al., 2005). However, irrespective of methods of Se supplementation
used, Se inadequacy in beef cattle is still a global problem. This is partly due to usage
of inorganic forms of Se with low Se availability. Therefore, how to supply Se in
more available is an ongoing area of research. Organic Se can substantially improve
Se status of beef cattle and research is still ongoing to define out how to optimally
relieve the Se deficiency by organic Se. For this reason, and to understand whether
inorganic vs organic forms of dietary Se differentially affect cell function, it’s crucial
to understand Se metabolism.
Se Metabolism
Selenium metabolism consists of absorption, transfer, incorporation into body
proteins, and excretion of Se. In mammals, organic and inorganic Se forms follow
different metabolic pathways, although there are overlapping components. This
metabolism is affected by such factors as the chemical form of Se, level of Se in
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blood and tissues before supplementation, presence of various minerals and amino
acids in the diet, and concentration of Se in the diet (Thomson, 1998).

Absorption
The absorptive mechanisms for Se have not been fully characterized. Several
factors can affect efficiency of Se absorption, including the form of the element, the
amount that was ingested, and other dietary factors such as calcium, arsenic, cobalt
and sulfur can affect Se absorption by 50% or more (Surai, 2006). In general however,
most Se is efficiently absorbed in the small intestine (Schrauzer, 2000), just over half
is retained, (ie, not excreted in the urine) (Bugel et al., 2003), and subsequent
metabolism depends on the form in which Se is present in plasma (Fairweather-Tait et
al., 2010).
Balance trials with grower-finisher pigs evaluated sodium selenite vs Seenriched yeast at various dietary Se levels (0.1, 0.3, or .5 ppm Se). As dietary Se
levels increased, urinary Se increased more when pigs were fed sodium selenite
(Mahan and Parrett, 1996). Selenium retention (a percentage of Se intake) was greater
(P = 0.01) when organic Se (0.3 ppm of Se from Sel-Plex) was supplemented
compared with inorganic Se (sodium selenite) to broilers for 6-wk (Yoon et al,. 2007).
Selenium retention in the liver, kidney, pancreas and loin of growing-finishing pigs
was higher when pigs were fed organic Se (Se-enriched yeast) than the same amount
of inorganic Se (selenite Se). (Tian et al., 2006)
Different forms of dietary Se also are absorbed at different rates. It was
reported that selenate has the most efficient absorption, nearly 100%, but a significant
fraction is lost in the urine; 90% of SeMet is absorbed; SeCys is absorbed very well;
＞50% of selenite is absorbed and is better retained than selenate (US Food and
Nutrition Board, 2000). Even though selenate and selenite are more efficiently
10

absorbed, they are less retained vs the organic forms of Se, SeMet and SeCys
(Ammerman and Miller, 1975; Thomson et al., 1978; Schrauzer, 2000; Burk et al.,
2006). Thus, considering only tissue retention as a criterion, feeding organic forms of
Se may be the more efficient method of supplementing Se to animal diets.

Blood Transfer
After absorption, Se is transferred in blood bound to alpha- and gammaglobulins and delivered to the liver to synthesize selenoproteins (Ceballos and
Wittwer, 1996). It was reported that SeMet-Se is incorporated into a longer term body
pool than the selenite-Se: It is steadily incorporated into erythrocytes during a period
of 8-12 weeks and plasma Se reached a maximum 3-4 h after administration and
about 4-8 h sooner than after the administration of an equivalent dose of selenite;
selenite increased the blood until a plateau was reached after 7-8 weeks (Schrauzer,
2003).

Incorporation of Se into proteins
Selenium can be incorporated into proteins to form Se-containing proteins and
selenoproteins. The Se-containing proteins are proteins either with non-specific
incorporation of Se (usually SeMet) or specific Se-binding proteins. In contrast,
selenoproteins are specific proteins containing Se in the form of genetically encoded
SeCys (Behne and Kyriakopoulos, 2001; Almondes et al., 2010). Different from
proteins that bind zinc and copper to form coordinated to functional groups, SeCys
and SeMet residues are constituent residues in polypeptides (Suzuki, 2005).
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Selenium-specific Metabolic Pathways
General metabolism
The metabolism of organic and inorganic forms of Se have both common and
different metabolic fates. Selenate, selenite, SeMet, and SeCys all enter the selenide
pool and from here the Se is either converted to selenophosphate and used for
synthesis by specific tRNAs or excreted in the urine as a selenosugar (Schrauzer,
2003; Fairweather-Tait et al., 2010). Specifcally, SeCys and SeMet are thought to be
the most common forms of dietary OSe. In the ruminant, absorbed SeCys (originating
from dietary or microbial protein), will be transformed to selenide by cleavage of the
C-Se bond at the beta position by beta-lyase, this step is involved the production of
alanine (Ohta and Suzuki, 2008). Besides, the methyltransferases can transfer onecarbon groups to SeCys to become methylSeCys, the later will be converted to gamaglutamyl-Se-methyl-SeCys, methyl-seleno-pyruvate, or methylselenol that functions
as an intermediate of Se excretion and selenoprotein synthesis. The selenide
undergoes an ATP required reaction to synthesize the selenophosphate by
selenophosphate synthetase. The transfer RNA for selenocysteine will be
aminoacylated with serine to become tRNA[Ser]Sec, then binds with the
selenophosphate to form phosphoseryl-tRNA[Ser]Sec by O-phosphoryl tRNA Sec
kinase, and further converts to selenocysteyl-tRNA[Ser]Sec by the Selenocysteine
synthase. Along with some transcription factors, the selenocysteryl-tRNA[Ser]Sec will
bind to the UGA codon to synthesize the selenoproteins, however, SeMet can
incorporate into polypeptide chains using the same mechanisms of Met to synthesize
Se-containing proteins in whole body by the transfer RNA for Met, but it can also
transfer to SeCys similar to how Met transfers to Cys to synthesize selenoproteins
when the body is under a relative Se-deficiency environment. Also, SeMet can be
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transformed to methylselenol through cleavage of the C-Se bond at the γ-position of
SeMet and then the methylselenol is transformed to selenide.
Inorganic Se (selenite and selenate) are reduced to selenide by thioredoxin
reductases, and the resulting selenide used to synthesize selenoproteins. Selenate can
convert to selenite but this step differs from mammal compared to bacteria. In
mammals, the bifunctional enzyme phosphoadenosine-phosphosulfate synthase will
catalyze two steps. Sulfate adenylyltransferase catalyzes the formation of adenosine
5'-phosphosulfate (APS) from ATP and selenate, and APS is bound by
adenylylsulfate kinase portion of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)
synthase to selenite (Bandurski et al., 1956; Hilz and Lipmann, 1955; Venkatachalam
et al., 1998). In contrast, in bacteria, this reaction is carried out by selenate reductase
(Schroder et al., 1997; Macy et al., 1993; Krafft et al., 2000; Stolz and Oremland,
1999). At the same time, selenite can also be converted back to selenic acid, and the
latter adenylylated to adenylylselenate and then phosphoralated to
phosphoadenylylselenate. Both of these steps are catalyzed by bifunctional
phosphoadenosine-phosphosulfate synthase (Lehninger, 2005; Salway, 2004).
Oxidixed glutathionine (GSSG) can incorporate selenite to become GS-Se-SG,
and the latter then reduced to GS-SeH by gluthathione reductase. GS-SeH can
reversibly convert to selenide upon GSH conversion to GSSG. GS-SeH, also will bind
glycogen or carbohydrate group to produce the selenosugar A. Methylation of
Selenosugar A (with SAM acting as the methyl group donor) produces selenosuger B.
Selenosugar B is the principle Se metabolite when the body is in a low-toxic range of
Se (Kobayashi et al., 2002). Selenide can be converted back to methylselenol by
methylation, and the methylselenol will also be methylated into dimethylselenide,
which will be further methylated into trimethylselenide. These three reactions
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catalyzed by methyl transferase use S-adenosylmethionine (SAM) to donate the
methyl group (Ganther et al., 1966; Hsieh and Ganther, 1977; Suzuki et al., 2006b).
Methylselenol can be reduced to methyl-selenic acid through a reversible reaction
with thioredoxin reductase (MOORE et al., 1964; Speranza et al., 1973; Arner and
Holmgren, 2000). Toxic doses of Se is known to be excreted into urine in the form of
trimethylselenide and exhaled in the form of dimethylselenide (Kobayashi et al.,
2002).
The Se in inorganic selenite or selenate in the diet will either go into
selenoprotein or be excreted in the form of methylated Se or selenosugar. However,
Se in the organic form SeMet can be preserved in Se-containing proteins except for
synthesis of selenoprotein or excretion. The preserved Se from organic Se will be
used once the body is Se deficient or the requirement of Se is increased under stress
conditions (Surai, 2002).
Selenocysteine (SeCys)
SeCys is directly incorporated into the polypeptide chains of selenoproteins
(Böck et al., 1991). The existence of SeCys rather than cysteine increases the
enzymatic activity of selenoproteins as much as 100- to 1,000-fold (Burk, 2002).
Organic Se compounds are transformed to selenide through reductive cleavage of the
C-Se bond by lyase reactions (Suzuki, 2005). In contrast to Cys, SeCys residues from
selenoprotein degradation are not appreciably re-incorporated into proteins. Instead,
they are degraded in the liver to selenide by β-lyase, with the Cys residue re-utilized
for protein synthesis. Selenide is phosphorylated to selenophosphate, which will be
transformed to SeCys on SeCys-tRNA (21st aminoacyl-tRNA), and the
selenocysteinyl residue is incorporated into selenoprotein sequences.
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Incorporation of SeCys into selenoproteins requires five specific components.
They are: a SeCys-insertion sequence element (SECIS) in the 3’-untranslated region,
a SeCys codon (UGA) in the coding region, a SeCys-specific translation elongation
factor, the SeCysSeCystRNA, and a SECIS-binding protein (SBP2) (Suzuki, 2005;
Daniel and William, 2008).). The initial step in biosynthesis is the charging of serine
on the specific tRNASec by seryl-tRNA snythetase, followed by Ser-tRNAsec to SectRNAsec conversion, which is catalyzed by SeCys synthase, an enzyme that utilizes
phosphoserine as an intermediate to generate SeCys (Sturchler-Pierrat, et al., 1995).
The whole process included three different steps: aminoacylation of tRNA Sec with
serine by seryl-tRNA synthetase; transformation of serine to phosphoserine; and
conversion of phosphoserine to SeCys. The SECIS (SeCys insertion sequence)
element is an RNA stem-loop structure that resides in the 3’UTR of selenoprotein
mRNA. This SECIS element is mandatory for UGA recognition as Sec and not a stop
codon (Aeby et al., 2009). A stem loop structure that resides 7 nucleotides distant 3’
to the UGA Sec codon is the Se response element (SRE). Presumably, the SRE can
stimulate decoding of UGA (Nasim et al., 2000).
A number of protein factors also are essential for selenoprotein synthesis. For
example, EFSec (which binds only to the Sec-tRNASec) acts as the elongation factor
for selenoprotein B (SelB) and nucleotlin and NSEP1 are coeffectors that bind SECIS
(Lescure et al., 2002).
Selenomethione (SeMet)
The incorporation of SeCys into selenoproteins is known as the “regulated
pathway” of Se incorporation into proteins because of the obligate SECIS genetic
element (Suzuki, 2005). In contrast, the incorporation of Se into polypeptide chains
through SeMet is known as the “unregulated” pathway (Papp et al., 2007) because
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SeMet is directly incorporated into polypeptide chains. Furthermore, tRNAMet readily
recognizes SeMet and does not distinguish between SeMet and Met (Cowie et al.,
1959; Burk et al., 2001; Suzuki, 2005). Because SeMet and Met share the same codon,
the ratio of incorporation into proteins for SeMet is dependent on the SeMet:Met ratio
in feedstuffs, and excessive SeMet supplementation increases this ratio and the
incorporation content. Once proteins are synthesized, SeMet is retained at the presynthesis ratio of SeMet:Met (Suzuki, 2005). Once SeMet is metabolized as a
constituent of the Met pool, it is available to be incorporated randomly into cellular
proteins and is unaffected by specific Se-metabolism processes (Burk et al. 2001).
SeMet, however, can be metabolized to selenide through the trans-selenation pathway
or through the direct lyase reaction. Thus, the non-specific incorporation of SeMet in
place of Met in various proteins is a way of preserving Se for future use in the body
(Zeng, 2009; Hall et al., 2012).
The Se in SeMet can become available for regulated pathway-mediated
selenoprotein synthesis when catabolized to selenide by γ-lyase, especially during
periods of excessive SeMet intake (Behne, et al., 1992; Schrauzer, 2003). Then it
shares the exact same pathway to synthesize selenoproteins as SeCys. Gamma-lyase
activity also can yield methylselenol (CH3SeH), which has been identified as an anticancinogenic agent from SeMet produced selenide, whereas β-lyase produces Se from
MeSeCys during SeCys metabolism (Suzuki, 2005). Methylselenol is primarily
excreted in breath and urine after conversion to TMSe (Gabel-Jensen et al., 2010) but
may also enter the selenide pool via the reverse reaction by demethylase (FairweatherTait et al., 2010). The presence of γ-lyases in the liver suggests that the liver is the
primary site of SeMet degradation.
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Inorganic Se
The inorganic Se compounds selenite and selenate are commonly reduced to
selenide for further utilization or excretion, but their primary routes of metabolism
differ (Suzuki, 2005). For example, blood selenite is readily absorbed by red blood
cells (RBCs) whereas selenate ions are absorbed by hepatocytes through a transport
system for phosphate or excreted directly into urine (Suzuki, 2005). After absorption
by RBCs, selenite is readily reduced to selenide, effluxed into blood, and bound by
albumin for transfer to the liver. Subsequently, selenide and selenate are used by the
liver for synthesis of selenoproteins through incorporation into SeCys (Suzuki, 2005),
as described above.
Selenoproteins
Selenoproteins are defined as proteins which require SeCys incorporation into
their polypeptide chains. There are 25 selenoprotein genes in humans, and SeCys
residues were found in the active site of those that have been attributed a function
(Allmang et al., 2009). Most selenoproteins function as peroxidases. The first
mammalian protein identified as a selenoprotein was cytosolic glutathione peroxidase
(GPX-1) (Allan et al., 1999). Additional glutathione peroxidase enzymes have been
identified, including a glycosylated plasma glutathione peroxidase (GPX-2), a
gastrointestinal glutathione peroxidase (GPX-3), and a phospholipid-hydroperoxide
glutathione peroxidase (GPX-4) (Tham et al., 1998). Except for GPX-4, these
peroxidases exist as tetramers, with each subunit containing one SeCys residue (Allan
et al., 1999). The tetrameric forms catalyze the reduction of a variety of
hydroperoxides, including hydrogen peroxide, cumene hydroperoxide, t-butylhydroperoxide, and fatty acid hydroperoxides (Flohe 1989; Wiley et al., 1995). In
contrast, GPX-4, a monomer that contains one SeCys residue, catalyzes the reduction
of both fatty acid hydroperoxides and cholesterol hydroperoxides (Ursini et al., 1985).
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After reaction with a peroxide substrate, regeneration of the reduced active form of
the enzyme requires GSH (reduced glutathione). These selenoproteins have antioxidative activities in the body, and glutathione peroxidase and thioredoxin reductase
are thought to be the most abundant antioxidant enzymes in mammals (Gladyshev et
at., 1998).
Several selenoproteins, including selenoprotein P and W, and GPx 1, 3, and 4,
have been used widely as biomarkers of Se status (Brown and Arthur, 2001).
However, because selenoprotein P typically accounts for approximately half of the Se
in plasma, reaches a plateau after 2-4 weeks of supplementation, and is well
correlated with plasma Se across a wide range of Se status, it is often considered to be
the best biomarker of Se status (Fairweather-Tait, et al., 2010).

Excretion of Se
Selenium is excreted in urine (50 – 60%), in feces, and expired. However, Se
expiration only occurs when Se intake is extremely high (Suzuki, 2005). If toxic
levels of Se are not absorbed, the major urinary metabolite of Se is selenosugar. Two
different Se sugars have been identified: Se-glutathionyl-N-acetylselenohexosamine
(selenosugar-A) and Se-methyl-N-acetylselenohexosamine (selenosugar–B)
(Vadhanavikit et al., 1993; Kobayashi et al., 2002; Gammelgaard et al., 2008).
Selenosugar-A is thought to be the precursor for selenosugar B. Selenosugars are
thought to be produced principally by the liver, absorbed by kidney, then excreted
into urine (Suzuki, 2005).
However, if excessive Se is absorbed, it is excreted as methylated selenide in
the urine, mon-, di- (DMSe) and trimethylselenonium (TMSe) (Ali and Aboul-Enein,
2006). In addition, DMse is known to be exhaled (Vadhanavikit et al., 1993). The
ratio of the two major Se metabolites in urine changes depending on the Se dose, i.e.,
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at a lower dose, Se is excreted mostly as monomethylated Se, whereas TMSe is the
primary form of excretion when high levels of Se are consumed (Suzuki, 2005).

Toxicological and Nutritional Markers
Consumption of Se at or above a concentration of 2.0 μg/g diet or mL of
drinking water are toxic (Suzuki, 2005). As discussed above, TMSe becomes the
predominant form of Se excretion at these levels, at least in rats (Kobayashi et al.,
2002). Thus, selenosugars are assumed to be a nutritional marker for non-toxic Se
consumption whereas TMSe may be a toxicological marker (Kobayashi et al., 2002).

Ruminant Se Metabolism
Metabolism of Se by ruminants has common and uncommon components with
nonruminants.
Absorption and transfer
It has been reported that 75Se, as a selenic salt, was unabsorbed from the
rumen, slightly absorbed from the abomasum, secreted into duodenum and jejunum
with net absorption by the ileum (Wright and Bell, 1996). The absorbed Se was either
bound to carrier proteins, or existed as a free form, for transport to the liver and other
tissues. After absorption, Se metabolism in ruminants is similar to non-ruminants
(Ceballos and Wittwer, 1996).
Ruminant vs Nonruminant Se metabolism
The absorption and availability of inorganic Se is very low for cattle, with
only about 11 – 16% consumed being absorbed (Koenig et al., 1991; Koenig et al.,
1997) and about only 14% of that fed (136.9 of 973.3 µg/daily Se) was accumulated
in the cattle body (Kamada et al., 1998). Accordingly, absorption of inorganic Se in
ruminants is much lower than in monogastric animals. That is, absorption of orally
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administered 75Se for sheep was less than half that by swine and rats (34% vs 85%)
(Wright and Bell, 1966; Mason and Weaver, 1986), and the low net absorption and
bioavailability of Se for ruminants has been attributed to Se metabolism by rumen
bacteria (Kamada et al., 1998).
One reason for this low absorption of inorganic Se for ruminants may be the
Se-reducing conditions of the rumen and microorganisms influence. That is, rumen
bacterial convert inorganic Se into insoluble forms such as metallic Se or selenides
(Peterson and Spedding, 1963; Cousins and Cairney, 1961; Spears, 2003), which
results in decreased rates of absorption. The fate of inorganic Se that is absorbed by
microorganisms, is incorporation into microbial proteins (presumably as SeCys), thus
providing a source of organic Se for digestion and absorption by the ruminant
digestive tract. It has been shown that Se concentrations in bacteria isolated from
sheep rumen is 2.3 and 3.9 times the original dietary Se concentration of the forage
and concentrate diets, respectively (Koenig et al., 1997). Likewise, Se in the liquid
phase of digesta was largely protein-bound and, following hydrolysis of the microbial
cell protein, the element was absorbed as Se-containing free amino acids (Hidiroglou
and Jenkins, 1974). It is known that 6 h post dosing, 50% of Se was present in rumen
bacterial protein (Hidiroglou and Jenkins, 1974).
Different species of bacteria in the rumen metabolize inorganic Se into
different forms. For example, Selenomonas ruminantium can accumulate selenite into
SeCys, selenoethionine, SeMet and red elemental Se. However, some bacteria such as
Bacteroides ruminicola cannot incorporate selenite into organic compounds
(Hudmann and Glenn, 1984; 1985). In addition, the overall availability of inorganic
Se incorporated into bacterial proteins is very low, which means that a lot of inorganic
Se is unavailable for ruminant metabolisms. In contrast, the organic Se containing
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amino acids can be used for available Se directly. From this perspective, organic Se is
more bioavailable for for ruminants than inorganic forms.
The effect of Se supplementation on rumen bacterial fermentation
Dietary Se supplementation can affect rumen conditions and metabolism,
especially rumen microbial fermentation (Kim et al., 1997). It was reported that
rumen gas production was positively correlated with supplemented Se between 0.2
and 0.4 mg Se/kg dietary dry matter, and short chain fatty acid production was
optimal at 0.2 and 0.4 mg Se/kg dry matter but decreased significantly for
concentrations greater than 12.8 mg Se/kg dry matter (Von Brehm, 2001).
Excretion
Excretion of Se by cattle is through urine, feces, and exhalation. When Se is
administered via intravenous or subcutaneous injection of ruminants, urine is the
major route of excretion (Wright and Bell, 1966). The other principal route of Se
excretion in ruminants is the feces (Wichetel, 1998; Neathery et al., 1990; Podoll et al.,
1992).
Tissue specific Assimilation of Se
In mammals, Se is incorporated into red blood cells at time of their formation;
therefore, taking into account their life span (90-120 days) Se content of erythrocytes
reflects Se intake 1-3 months previous (Smith et al., 1997; Smith et al., 1998). It is
generally accepted that Se concentration in serum or plasma reflects short-term Se
nutritional status, whereas whole blood (erythrocyte) Se and GSH-Px activity are
more indicative of long-term Se status (Thompson et al., 1998).
Se preferentially accumulates in tissues such as endocrine glands, brain, and
reproductive organs (Allan et al., 1999). In the liver, dietary Se is metabolized to
selenide and then incorporated as SeCys into selenoprotein P, the physiological form
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that distributes Se from the liver to peripheral tissues and other organs (Dumont et al.,
2006). The kidney can synthesize the other major plasma selenoprotein, GPX3. In the
liver and kidney, cellular GPx was detected as the carrier of endogenous Se (Suzuki
and Ogra, 2002). Many tissues can indiscriminately incorporate SeMet into proteins
in competition with Met, and both the liver and extra-hepatic tissues have been
predicted to metabolize SeMet to multiple end products with the potential for
biological activity. The inter-tissue (liver, kidney, serum, and urine) distribution of
selenite and selenate Se was determined after intravenous injection (Suzuki and Ogra,
2002). Red blood cells take up selenite and selenite is reduced by glutathione to
selenide, which was is transported to plasma, selectively bound to albumin, and
transferred to the liver (Shiobara and Suzuki, 1998).

Manipulation of Inorganic Versus Organic Se Metabolism
Organic versus inorganic Se tissue assimilation
It is generally accepted that tissue assimilation of organic Se is greater than
assimilation of inorganic Se in cattle. Serum Se concentrations tended to be uniformly
higher during and at the end of the trial in beef cattle given Se yeast compared to
selenite (Fisher, 1995; Fisher et al., 1995). The supplementation of organic versus
inorganic Se (0.2 mg/day) for 8 weeks to Se-deficient cattle resulted in increased
blood Se of 5.6 to 167 (Se-yeast) per µg/L versus91 µg/L (selenite) (Malbe et al.,
1995). Selenium (0.75 mg daily) from the Se-yeast maintained Se concentrations in
whole blood and milk at the same levels as Se 3.0 mg in the form of sodium selenite
and Se (3.0 mg) from the yeast product increased blood Se by 40% and that in milk by
100%, compared to the equivalent amount of inorganic selenite (Ortman and Pehrson,
1997). The Se concentration in plasma was 1.26 fold higher for heifers supplemented
with Se-yeast compared to sodium selenite (Weiss, 2003). Furthermore, a 20 to 30%
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increase in whole blood Se levels was associated with organic Se supplementation
(Sel-Plex, Alltech, Inc.) compared to inorganic Se (Eliott et al., 2005).
Organic Se versus inorganic Se on Se bioavailability
Because serum Se concentration can reflect the GSH-Px activity of beef cattle,
the serum Se concentration was used as the value to measure the bioavailability of Se
in beef cattle. It should be mentioned that dietary Se is highly correlated to GSH-Px
when animals are deficient in Se, but the relationship weakens as animals become
adequate in Se (Stadmore et al., 1982; Combs and Combs, 1984; Kincaid, 1999; Rock
et al., 2001). Thus, after reaching a certain concentration of Se in the blood, which is
necessary for maximum expression of GSH-Px, there is no further increase in the
enzymatic activity of GSH-Px.
In general, the bioavailability of organic Se was superior to inorganic Se. The
relative bioavailability (selenite=1) of yeast Se was 1.4 if blood GSH-Px, 1.9 if blood
Se, and 2.7 if milk Se was used as the response criterion (Malbe et al., 1995). The
bioavailability of Se (GPx activity in the erythrocytes) for Se-deficient heifers
supplemented with Se-containing yeast for 12 weeks was about twice that than for
heifers supplemented with equal amounts of inorganic sources (Na or Co selenite)
(Pehrson et al., 1989).
Genotype can also affect the Se bioavailability. The Se bioavailability
response by humans after 6 wk of Se supplementation with 100 μg sodium selenite/d
was influenced by genetic polymorphisms in the selenoprotein P (SEPP) and GPX4
genes. These biomarkers (plasma Se, selenoprotein P, and GPx3) that used to assess
Se bioavailability were associated with 2 common single nucleotide polymorphisms
in SEPP in both baseline and post-supplementation samples, and the GPX4
polymorphism was shown to influence lymphocyte GPx4 concentration and other
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selenoproteins in vivo (Meplan et al., 2007). A single nucleotide polymorphism in
GPx1 was associated with Se deficiency and impaired GPx1 activity (Lei et al., 2009)
and also may be associated with a different response of GPx1 activity to Se
(Jablonska et al., 2009). It is possible that common polymorphisms in selenoprotein
genes, such as SEPP, GPX1, GPX4, and selenoprotein S (SELS) will have a
significant effect on the metabolism of dietary Se and will generate differences in
bioavailability. This possibility warrants further investigation.
Organic versus inorganic transfer of Se into colostrum and milk
It is well known that cattle have a limited ability to transfer Se into colostrum
and milk when sodium selenite is used as a dietary supplement. It was found that
organic Se in the ruminant diet contributes to higher Se concentration in colostrum
and milk, which could help to build antioxidant system of newborn calves through the
antioxidant activity of Se (Slavik et al., 2008).
It was reported that Sel-Plex supplemented diets had 67% higher milk Se
content within 2 weeks of initiating supplementation than when sodium selenite was
supplemented. Furthermore, somatic cell counts were significantly reduced 30% as
early as 2 weeks after inclusion of Sel-Plex, and that this trend continued throughout
the 6 week supplement period (Duarte et al., 2004). Similarly, inclusion of Se (0.2
ppm) in the form of sodium selenite (0.2 ppm) into the cattle diets provided 2.2 mg
Se/day for 8 weeks was associated with an increased Se level in milk (0.138 mg/L
versus 0.048 mg/L) and decreased somatic cell counts (174,500 versus 229,300)
cells/mL (Foltys et al., 2004). The inclusion of Sel-Plex Se in cattle diets at 2 or 6 mg
Se/day was associated with increased Se concentration in the milk from 6.9 up to 15.0
and 25.2 ng/ml, respectively, compared to inorganic Se (McIntosh and Royle, 2002).
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The replacement of sodium selenite with Sel-Plex also has been associated
with a significant increase in Se concentration in colostrum from 2.67 to 6 mg/day,
and was associated with an increase in Se concentration in colostrum after the first
two milkings by 42%, and after the first 8 milkings by 35% (Lewis, 2004). Others
found that only 4.8% of Se was transferred to milk if sodium selenite was added,
whereas 19% of the Se appeared in milk if organic Se was fed (Waite et al., 1975;
Conrad and Moxon, 1979) and that the efficiency of Se transfer to milk of cattle fed
Se-yeast ranged from 9.9 to 12.5%, compared with 2.4-4.1% for cattle fed sodium
selenite (Givens et al., 2004).
Differential Organic Versus Inorganic Se Form Effects on Immune and Health
Status
Many experiments have reported that organic Se supplement can contribute to
higher Se concentrations in blood, liver, and milk, accompanied by improvement of
animal quality, in particular with improved immunity and health. It was shown that
organic Se supplementation of cattle diets could maintain high Se status during all
periods of ontogenesis and to maintain high productive and reproductive
performances in stress conditions of commercial meat and milk production (Lyons et
al., 2007). Experimental data have included a number of observations such as:
increased GSH-Px activity in erythrocytes, decreased somatic cell counts, improved
health, and production and reproduction parameters in cattle supplemented with
organic Se (Cortinhas et al., 2010).
During stress, the activity of proteosomes increase to provide amino acids
needed for the formation of immune defense cells and enzymes, including Sedependent GSH-Px and thioredoxin reductases (Surai, 2006). During such times,
SeMet in proteins can be released y protein catabolism, thus providing a source of Se
needed for synthesis of GSH-Px and other selenoenzymes. Because the SeMet can be
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incorporated as “Met” through the non-regulated pathway, SeMet can be re-used
(Suzuki, 2005).
The advantages of organic Se supplementation compared to inorganic Se
include: 1. higher concentration of Se in the blood, milk, and tissues of cattle with Seyeast compared to inorganic Se supplement; 2. long-term supplementation of cattle
dies with Se-yeast does not result in toxic accumulations of Se, 3. beef calves whose
dams were supplemented with Se-yeast had a higher Se status than calves whose
dams were supplemented with selenite (Surai, 2006); 4. Se-yeast proved to be more
effective in stimulating weight gains and liver Se concentrations than sodium selenite
(Surai, 2006); 5. Se-yeast was more effective than sodium selenite in raising and
maintaining adequate Se concentrations in tissues of beef cattle (Ortmana, 1999; Valle,
2001).
Overall, dietary Se supplementation in inorganic forms does not appear
adequate to meet high Se demand of growing, reproducing, and lactating animals, and
is less than adequate for further metabolism due to reduction to metallic Se or selenide
by rumen bacteria and much lower retention level than organic Se. The feeding of
organic Se, such as selenized yeast, results in increased Se concentrations in blood
and GSH-Px activity. For example, Se concentration is doubled in colostrum and milk,
and the Se transfer through placenta is greater when Se supplied as OSe than ISe
(Surai, 2006). As a result, cattle health is improved with lower somatic cell counts,
decreased mastitis and retained placenta and improved conception rates. The benefit
to newborn calves is due to improved antioxidant defense and thermoregulation
leading to better immunity, viability and lower mortality during first months of the
postnatal development. It is also beneficial that organic Se SeMet can build Se
reserves in their tissues, in particular in muscles and those reserves can be effectively
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used by cattle in stress conditions when Se requirement is increasing while feed
consumption is declining (Surai, 2006).
Effect of Se supplements on Aspects of Beef Cattle Physiology
The effect of supplementation of Se for beef on blood Se concentration and
GSH-Px activity, selenium status in their calves, and immune status has been studied.
Supplementation of Se has higher Se concentration and GSH-Px activity than nonsupplemented beef. Cattle provided supplemental 2.5 mg/d Na selenite or Se-yeast
(Sel-Plex; 2.5 mg/ d) had greater liver and plasma Se concentrations and greater
plasma GSH-Px activity compared with control steers on day 60 and 90 (Arthington,
2008). Copper and Se supplementation to cattle maintained GSH-Px activity within
normal range, compared to the non-supplemented animals that had GSH-Px activity
was below the normal range (Minatel et al., 2002). Both 1.7 mg supplemental Se/d as
sodium selenite and Se yeast increased blood Se concentrations of beef calves
compared to the non-supplemented group (Fry et al., 2005).
Selenium content was positively correlated with the GSH-Px activity and
antioxidative ability. The mean value of Se concentration in whole blood and GSH-Px
activity of calves fed a basal diet and a ready-made fodder mix that contained 0.1
mg.kg(-1) selenium were higher than the non-supplemented group and was correlated
with Se concentration in whole blood and GSH-Px activity (Harapin et al., 2000).
Examination of blood serum and meat samples of clinically healthy Limousine and
Angus calves grazed on grass pasture was negatively correlated with blood serum
repetitive strain injuries and selenium content, which means a positive effect of Se
content in beef on the protective antioxidative processes in blood serum (Matthes et
al., 2002). However, even though supplementation of Se leads to increased serum and
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tissue Se concentrations, these differences may not be concomitant with altered
animal performance (Richards and Loveday, 2004).
Supplementation of beef cows with Se can maintain Se content and GPH-Px
activity and immune response for their calves. At 180 d after birth, blood Se
concentrations for calves of dams subject to no Se supplementation during day 115130 of gestation were deﬁcient (<50 µg Se/L), but Se yeast supplementation maintain
an adequate Se level (188 µg of Se/L), and the liver Se content of calves was greater
of supplemented group than control group (Davis et al., 2005). Supplementation with
Se of pre-weaning calves increased whole blood Se concentration and GSH-Px and
tended to increase in vivo cell-mediated immune response compared to Se deficient
non-supplemented calves at 22 day after weaning (Beck et al., 2005). Also, placental
transfer of Se is more efficient than milk transfer for calves from cows that received
Se supplementation (Enjalbert et al., 1999).
Supplementation of Se can decrease infectious disease challenge and promote
antibodies in response to antigen challenges. Titers of infectious bovine
rhinotracheitis virus in steers increased from d 0 to 7 after the infectious challenge and
decreased from day 7 to 21 in the Sel-Plex and selenite steers but continued to
increase through 21 d after the challenge for non-supplemented steers (Covey et al.,
2010). Also, it was reported that although supplementation of 1.7 mg Se/d had
minimum effects on immune function of weaned beef steers (Fry et al., 2005), blood
Se levels over 100 mg L-1 are needed to maintain optimum immunocompetence
(Nicholson et al., 1993).
The effect of organic versus inorganic Se supplementation on bioavailability
and immunocompetence in beef cattle has been initially evaluated. The
supplementation of organic Se to diets of weaned beef steers increased Se content and
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GSH-Px than inorganic Se (Fry et al., 2005). Supplementation of organic Se resulted
in more available Se for calves than inorganic Se. Organic Se supplementation also
resulted in higher immunocompetence than inorganic Se. Also,supplementation of Seyeast of pre-weaning calves increased macrophage phagocytosis compared with
sodium selenite (Beck et al., 2005). The ability of yearling beef cattle supplemented
with Se to produce antibodies in response to antigen challenges with sheep red blood
cells and ovalbumin tended to be higher for Se-enriched yeast than inorganic Se
supplemented cattle (Nicholson et al., 1993). This greater effect by organic Se versus
inorganic Se in ruminants could be a result of the rumen microbial reducing
conditions converting inorganic Se into low available insoluble forms. However,
without conversion, the organic Se can be used directly.
In summary, dietary Se supplementation in inorganic form is not adequate to
meet high Se demand of growing, reproducing and lactating animals, and is less than
adequate for further metabolism because of reduction to metallic Se or selenide by
rumen bacteria, resulting in much lower retention level than organic Se. The organic
Se such as selenized yeast in the form of Sel-Plex is better than inorganic Se due to
increased Se concentration in blood and GSH-Px activity, approximately doubled Se
concentration in colostrum and milk, higher Se transfer via placenta. As a result, cattle
health is improved with lower somatic cell counts, decreased mastitis and retained
placenta as well as improved conception rates. The benefit to the newborn calves is
due to improvement of their antioxidant defenses and thermoregulation leading to
better immunity, viability and lower mortality during first months of the postnatal
development. It’s also beneficial that organic Se SeMet can build Se reserves in their
tissues, in particular in muscles and those reserves can be effectively used by cattle in
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stress conditions when Se requirement is increasing while feed consumption is
declining.
Effects of Se Supplementation on Hepatic Gene Expression
Selenium supplementation increased the expression of genes involved in
antioxidant defense, lesion-protection, and apoptosis under the tumorigenesis. cDNA
array showed that Se deficiency in rats led to a down-regulation of Se-dependent
cGPx, significant down-regulation of genes important in the inhibition of apoptosis
(defender against cell death 1 protein, Bcl2-L1), cell cycle (G1/S-specific cyclin D1)
and antioxidant defense (gamma -glutamylcysteine synthetase catalytic subunit).
Furthermore, an induction of genes encoding for detoxifying enzymes in liver
(cytochrome P450 4B1, UDP-glucuronosyltransferase 1), and combined vitamin E
and Se deficiency affects the expression level of genes encoding for proteins involved
in inflammation (multispecific organic anion exporter, SPI-3 serine protease inhibitor)
and acute phase response (alpha-l acid glycoprotein, metallothionein 1) ( Fischer et al.,
2001). Dietary Se deficiency decreased mRNA levels of 7 common genes (Gpx1,
Gpx4, Sepw1, Sepn1, Sepp1, Selo, and Selk) coding for selenoproteins involved in
oxidation- and/or lesion-protective effect in liver of chicks (Huang et al., 2011). Sesupplemented diets also increased expression of SelW and selenocysteine-synthase in
the liver of chickens compared to non-Se-supplemented chickens (Sun et al., 2011).
Supplementation of Se for 2 weeks to rats reduced protein kinase c-alpha (PKC-alpha)
gene overexpression in preneoplastic liver and the formation of preneoplastic lesions
in the liver (Chen, 1993). Furthermore, 2.1 mg Se/kg Se-enriched broccoli diets for 10
weeks increases and ikBalphakappaB, hsp86, gadd45 gene transcripts and activates
pro-apoptotic genes linked to p53, NFkappaB in response to "danger signals" such as
tumorigenesis to the liver of rats compared to 0.11 mg selenium/kg control diet (Zeng

30

et al., 2003). The increased antioxdative capacity induced by those genes could
explain the better immune-competence for Se supplemented beef cattle.
As for genes involved in iron metabolism, the expression of transferrin,
transferrin receptor, and iron regulator protein1 mRNA were more abundant in Sedeficient (non-supplemented Se) than in Se-adequate (0.15 mu g Se/kg as sodium
selenite for 15 wk) liver (Christensen et al., 2000). In addition, supplementation of Zn
and Se can protect against Cd-induced toxicity by alteration of metallothionein gene
expression in the liver of rats (Banni et al., 2010).
The mRNA levels for transthyretin and citrate transport proteins are both
reduced in the livers of Se-deficient rats compared to Se supplemented rats with 0.5
mg Se/kg diet for 13 weeks (Kendall and Christensen 1997). The solute carrier gene
Slc48a1 is up-regulated in the liver of rats with selenium-deficient diets compared to
selenium-supplemented diets (Mallonee et al., 2011).
Other genes found to be differentially expressed upon Se supplementation
compared to non-Se supplementation are involved in other metabolic pathways. The
mRNA levels for liver estrogen sulfotransferase isoform-6 alpha 2u-globulin were
markedly reduced in Se deficiency compared to rats supplemented Se with 0.5 mg
Se/kg diet as sodium selenite to the rats for 13 weeks (Yang and Christensen 1998).
Furthermore, 50 g/kg Se supplementation for 60 days down-regulated the expression
of phospholipase D mRNA in the liver of diabetic rats compared to non-supplemented
rats (Wu et al., 2006).
Organic and inorganic Se supplementation also differentially affects the gene
expression of liver. Genes in the liver of mice related to the selenoproteins Gpx1, Selh,
Sep15, and Sepw1, were differentially expressed among Se supplemented diets
(sodium selenite, SeMet, or a yeast-derived Se) (Mallonee et al., 2011). Also, in mice,
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non-selenoproteins encoded by Se-responsive genes including transport and stress
response are differentially induced by three Se supplemented diets (Mallonee et al.,
2011). Because most of selenoproteins function as peroxidases, the different
expression of genes related to selenoproteins, and some genes related stress response,
upon organic versus inorganic Se supplements could explain the different
antioxidative capacity of beef cattle supplemented with organic forms of Se.
In summary, Se supplementation has different effects on the expression of
genes in the liver compared to non-supplements. Differentially expressed genes are
involved in 1) oxidation/lesion, apoptosis; 2) iron metabolism; 3) carrier proteins and
transporters; 4) other metabolisms.
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Chapter 3: Hepatic transcriptome profiles differ among maturing beef heifers
supplemented with inorganic, organic, or mixed (50% Inorganic:50% Organic)
forms of dietary selenium
Introduction
Selenium is a metalloid belonging to Group VIA of the Periodic Table, the
same as sulfur. Selenium plays an important role in regulation of various
physiological functions in beef cattle including immunity, reproduction and early
postanatal viability (Suzuki, 2005). Selenium deficiency alone, or in combination with
vitamin E, is associated with reduced growth and productivity rates, early mortality
and immune-suppression. Se deficiency has been specifically linked with the
development of various diseases in ruminants (Pehrson, 1993; Kolb and Seehawer,
2001) including nutritional muscular dystrophy (white muscle disease, the most well
documented disease related to Se/vitamin E deficiency in ruminants), retained
placenta and metritis (affecting about 9% of USA dairy industry births), and mastitis
(estimated annual cost is $17,500 for a 100-cow herd) (Surai, 2006).
The concentration and availability of Se in the soil primarily determines the Se
content of forages .The Se requirement for beef cattle among all ages is 0.10 mg
Se/kg of diet daily (NRC, 2000). The Se content in forages (and grains) of the
southeast USA (including Kentucky) is low (＜ 0.05 mg Se/kg) to variable (＜ 0.1
mg/kg) (Ammermann et al., 1975). Consistently, a survey of whole blood Se
concentrations of beef cows and heifers from 253 cow-calf operations in 18 states
found that 42% of southeastern USA (including Kentucky) cattle were Se deficient
(≤0.080μg/mL), as opposed to 18% nationally (Dargatz and Ross, 1996). Therefore,
Se supplementation of forage-based diets is necessary in Kentucky.
Supplementation of diets with Se is regulated by the Food and Drug
Administration and cannot exceed 120 mg Se/kg, or an intake of 3 mg per day, when
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delivered in free-choice mineral supplements to cattle (FDA, 1987). Diets can be
supplemented with inorganic or organic forms of Se. Sodium selenite and sodium
selenate are the typical forms used, despite the knowledge that Se primarily is present
in plants as organic forms. Organic forms of Se include selenomethionine (SeMet)
and selenocysteine (SeCys). However, commercial animal diets are not directly
supplemented with SeMet or SeCys. Instead, SeCys and SeMet are supplied as
constituents of Se-enriched yeast extracts (e.g., SeMet is the predominant form of Se
in Sel-Plex (Alltech Biotechnologies, Inc., Nicholasville, KY) (Korhola et al., 1986).
The effect of supplementing diets with inorganic versus organic Se
supplements on Se bioavailability (concentrations of Se in blood and tissues) and
bioactivity (blood glutathione peroxidase activity) have been compared. For example,
assimilation of Se after 105-106 days by whole blood, red blood cells, and biopsied
liver tissue was greater for slow maturing beef heifers fed 3 mg/day of Se as Sel-Plex
than for sodium selenite (Liao et al. 2011). Similarly, Se concentrations (µg/g) in the
skeletal muscle of cows supplemented with 3 mg/day as Se-yeast was 1.5-2.5 fold
higher than when supplemented with sodium selenite (Ortman and Pehrson,1999).
With regard to the effect of organic versus inorganic Se on animal
performance under stress conditions, supplementation of Se in organic forms is
known to decrease the mean milk somatic cell counts more than inorganic forms in
experimental (McIntosh et al., 2002) and commercial (Harrison et al., 2005) cow
herds. However, supplementing cattle diets with organic versus inorganic forms of Se
did not affect the average daily gain of heifers supplemented with 3 mg Se/day as
sodium selenite or Sel-Plex® for 105-106 days (Liao et al., 2011). Likewise, there was
no difference on the final body weight, average daily gain, or gain-to-feed ratios of
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slow maturing beef heifers supplemented with 3 mg Se/day as sodium selenite, SelPlex, or a 1:1 mix of sodium selenite and Sel-Plex for 224 days (Brennan et al., 2011).
To better understand effect of supplementing beef cattle diets with different
forms of Se on hepatic function and hepatic Se-specific metabolism, so that
appropriate dietary Se supplementation regimens for beef cattle can be developed, it
would be usefull to understand if hepatic gene expression profiles differed in beef
cattle fed the same diet but containing different forms of Se supplement. Achieved
differences in small RNA (mRNA, miRNA) profiles would be indicative of altered
physiological capacities. Our previous study examining the effects of organic versus
inorganic 3 mg Se/day supplementation for 105 - 106 days on hepatic gene expression
profile of beef cattle (Liao et al., 2011) revealed that organic and inorganic Se
supplements commonly and differentially affected the hepatic gene expression
compared to non-supplemented animals. These Se form-induced differences
corresponded with 18 and 59% increases in hepatic content of Se by the inorganic and
organic Se supplements. However, because only a single sample point (day 105/106)
was used, it was not known if stabilization of hepatic Se assimilation had been
achieved. Thus, conclusions about whether observed Se form induced difference in
liver gene expression profiles represented stable or transient changes could not be
drawn.
To address this issue, and to determine the effect of a mix of inorganic and
organic forms (Mix) consisting of 1.5 mg Se/day as sodium selenite and 1.5 mg
Se/day as Sel-Plex®, a second experiment using the same animal model (maturing
beef heifers gaining 0.5 kg/day on a cottonseed hull-based diet) was conducted over a
224-day period using (n = 10) none (Control) or 3 mg Se/day dietary supplement
treatments as sodium selenite (ISe), Sel-Plex (OSe), or Mix to determine the effect of

35

Se supplement form on tissue assimilation of Se (Brennan et al., 2011). Se
assimilation (µg/g) by liver tissue of ISe, OSe, and Mix treatment heifers was
maximal and stable from d 56 throught d 224 for all treatment groups, but the amount
of Se assimilated by liver tissue was dependent on the Se treatment (OSe = Mix > ISe >
non-supplemented Control heifers).
Using the liver tissue collected from these (Brennan et al., 2011) maturing
beef heifers that had assimilated Se supplement form-specific amounts of Se, the
objectives of the current work were to (1) compare hepatic gene transcriptome
profiles when hepatic liver assimilation was stable (d 168) using microarray methods,
and (2) conduct bioinformatics analysis of these profiles to predict altered hepatic
physiological capacities induced by specific forms of Se supplement.

MATERIALS AND METHODS
Source of Liver Tissue, Experinetal Treatments, and Liver Se Concentrations
The liver tissue samples used were from the animals of the Brennan et al. (2011) trial,
for which all animal procedures were approved by the University of Kentucky
Institutional Animal Care and Use Committee. Specific descriptions of the animal
model (Brennan et al., 2011) and liver biopsy procedures used (Brown et al., 2009;
Brennan et al., 2011) have been described. However, briefly, at the end of a common
Se depletion period and diet-adaptation period, heifers were ranked (in groups of four)
on the Se concentration of their biopsied liver sample. Within a rank, heifers were
randomly assigned (n=10/treatment) to one of four dietary Se supplementation
treatment groups, to stratify similar basal liver Se content among treatment groups.
For the control treatment (Control) no exogenous source of Se was supplied to the
basal mineral-vitamin premix. For the ISe, OSe, and a 1:1 combination of ISe and
OSe (Mix), the basal mineral-vitamin premix was supplemented with sodium selenite
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(ISe, Prince Se Concentrate; Prince Agri Products, Inc., Quincy, IL, USA), Seenriched yeast (OSe, Sel-Plex®, Alltech Inc., Nicholasville, KY, USA), or their
combination, respectively. The Control, ISe, Mix, and OSe mineral-vitamin pre-mixes
contained 1.09 mg/kg, 36.1 mg/kg, 34.74 mg/kg and 34.56 mg/kg of Se, respectively.
Animals were weighed biweekly and intake of the basal diet adjusted, to ensure
animals maintained an average daily gain of 0.5 kg/day. The daily supply of Se for
each of the ISe, Mix, and OSe treatment rations was calculated to provide 3.0 mg/day.
After biopsy, the liver sample from each animal was placed in foil packs,
snap-frozen in liquid nitrogen, and stored at -80°C until analyzed for Se concentration
or RNA extraction. The liver Se concentrations were analyzed as previously reported
(Brennan et al., 2011) by Donald C. Mahan (The Ohio State University, Columbus,
OH, USA) and differences in Se-form treatments reported (Brennan et al., 2011).
Specifically, Se concentrations in liver were greater (P ≤ 0.01) in all three Sesupplementation treatment groups than the non-supplemented Control group, whereas
liver Se concentrations of Mix heifers were greater (P = 0.01) than for ISe heifers,
OSe heifers tended (P = 0.08) to be greater than ISe heifers, and Mix heifer liver Se
concentrations did not differ (P = 0.20) from OSe heifers (Brennan et al., 2011).
RNA Extraction and Analysis
For each animal, total RNA was extracted from 400 mg of frozen liver tissue
using TRIzol Reagent (Invitrogen Corporation, Carlsbad, CA) following the
manufacturer’s instructions. The purity and concentration of total RNA samples was
analyzed by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies,
Wilmington, DE), which revealed that all samples were of high purity with 260/280
absorbance ratios of 2.0-2.1 and 260/230 absorbance ratios ranging from 1.5 to 1.9.
The integrity of total RNA was examined by gel electrophoresis using Agilent 2100
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Bioanalyzer System (Agilent Technologies, Santa Clara, CA) at the University of
Kentucky Microarray Core Facility. Visualization of gel images and
electropherograms showed that all RNA samples had high quality with RNA integrity
numbers (RIN) being greater than 8.8 and 28S/18S rRNA absorbance ratios greater
than 1.8.
Microarray Analysis
The custom WT Btau 4.0 Array (version 1) (GeneChip; Affymetrix, Inc.,
Santa Clara, CA), which contains 26,303 bovine gene transcripts, was used.
Microarray analysis was conducted according to manufacturer’s standard protocol at
the University of Kentucky Microarray Core Facility. Briefly, 3 g RNA for each
sample was reverse-transcribed to cDNA first, and then from cDNA (double-stranded)
to cRNA (single-stranded) which were then labeled with biotin. The biotinylated
cRNA were further fragmented and used as probes to hybridize the GeneChips in the
GeneChip Hybridization Oven 640, using 1 chip per RNA sample. Due to the loss of
one animal, and failure to obtain one liver sample, the experimental observations for
each treatment were as follows: n = 9 (one missed sample), 9 (one animal died), 10,
and 10 for Control, ISe, Mix, and OSe treatments, respectively.
The raw expression intensity values from the 38*.cel files from the raw
methylation measurements were imported into Partek Genomics Suite software (PGS,
version 6.66 beta; Partek Inc., St. Louis, MO). For GeneChip background correction,
the algorithm of Robust Multichip Averaging adjusted with probe length and GC
oligo contents was implemented (Irizarry et al., 2003; Wu et al., 2004). The
background-corrected data were further converted into expression values using
quantile normalization across all the GeneChips and Median Polish summarization of
multiple probes for each probe set (Partek, 2009). The similarity matrix was generated
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by Pearson (Linear) Correlation and was converted to heat map to visualize the
correlation among chips. One Mix and one OSe treatment chip were identified as
outliers because of their relatively low correlation with any of other GeneChips. The
average correlation between any pair of GeneChips 38 was 0.975 except for two of
the chips (one belonged to Mix, and one to OSe) that had correlations of about 0.943
and 0.837 with the other chips (Figure 1a). These two chips were removed prior to
further statistical analysis. New correlation heat map (Figure 1b) after removing
outliers showed no outliers, the final correlation meets the 0.984. The remaining 36
*.cel files (n=9 for each of the Se treatments) were imported into PGS and subjected
to the background correction and normalization as decided above.
GeneChip transcripts were annotated using the NetAffx annotation database
for Gene Expression on Bovine GeneChip Array, provided by the manufacture and
last updated September 2011. When appropriate, incompletely annotated transcripts
were subjected to GenBank analysis and annotation updated. Quality control of the
microarray hybridization and data presentation was performed by MA-Plot on all
gene expression values and Box-Plot on the control probe sets on Affymetrix
GeneChips (data not shown).
Principle component analysis (PCA) was conducted to determine the quality
of the microarray hybridization and visualize the general data variation among the
chips (Partek, 2009). Differentially expressed genes (DEG) were subjected to
hierarchical clustering (Partek, 2009) and Ingenuity Pathway Analysis (IPA, 8.7-3203;
http://www.ingenuity.com; Ingenuity Systems, Inc., Redwood City, CA).
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MicroRNA analysis
Selected microRNA (miRNA) were imported into the miRNA database
(http://www.mirbase.org/index.shtml) to search and browse their hairpin precursor
and mature sequences, and their annotation, including accession or ID or pubmed ID.
To predict their targets, miRNA sequences were imported into the TargetScan
(http://www.targetscan.org). The biological targets of Bos taurus miRNA were
identified by searching for the presence of (1) conserved branch length sites that
matched the seed region of each miRNA (Lewis et al., 2005), (2) sites with
mismatches in the seed region that are compensated by conserved 3’ pairing
(Friedman et al., 2009), (3) and poorly conserved sites. Putative miRNA targets were
compared to DEG found to be affected (P < 0.01) by Se treatment. The DEG that
were putative targets of miRNA were subjected to the miRNA Target Filter analysis
component of IPA.
Statistical Analyses
Animal was the experiment unit and one GeneChip per animal was used to
evaluate relative hepatic mRNA content in response to Se treatment. Se treatment
effects on expression of all 26,303 array transcripts were determined by ANOVA.
Source of variation analysis determined the sources of variation associated with
treatment and error by calculating the mean F ratio of all 26,303 transcripts by Partek
Genomic Suite (6.66 beta version) software. Gene transcripts were considered
differentially expressed at P < 0.01. Treatment least square means of DEG were
separated using the pdiff option of SAS (9.2 version, SAS Inst., Inc., Cary, NC, USA).
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RESULTS
Principle Compent Analysis (PCA)
The mean F ratios for treatment and error were 0.90 and 1.00, respectively
(data not shown). Principle component analysis revealed a total variance of 16.7%
(Figure 2). The principal component (PC #1, x-axis) contained transcripts with a
higher degree of variance 9.08%, whereas PC #2 (y-axis) encompassed genes that had
lower 7.58% ranges of variance. In general, the GeneChips within each treatment
group were clustered together and the Control, OSe, and Mix treatment groups were
clustered closer than the ISe.
Se Treatment-specific Profiles of Differentially Expressed Genes (DEG)
Analysis of variance analysis found that the expression of 139 transcripts were
differentially affected (P < 0.01) by Se supplementation (Table 1). Of the 139 DEG,
the nucleotide or protein sequences have been validated. The range for Se treatment
induced expression of annotated genes renged from 2.67-fold upregulated (BOLADQA20) to 1.65-fold downregulated (MIR2393). Among these 139 DEG some were
uniquely and some commonly affected by Se treatment (Figure 3). Relative to
expression by Control heifers, 32 genes were solely affected by ISe treatment, with
another 22 and 4 being commonly affected by ISE and Mix or OSe treatments,
respectively. In contrast, OSe supplementation solely affected the expression of 22
genes and commonly the expression 4 and 7 genes with ISe and Mix, respectively.
For the Mix treatment, 33 genes were solely affected, but another 22 and 7 were
commonly expressed with ISE and OSe, respectively. In addition, 11 genes were
affected commonly by all three Se supplementation treatments relative to Control,
whereas the expression of another 8 genes were differentially expressed among ISe,
Mix, and OSe treatments, but did not differ from Control expression levels.
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Bioinformatic Analysis of Se Treatment-specific Profiles
In total, 69 (ISe), 73 (Mix), and 44 (OSe) DEG were solely or commonly
affected by Se supplementation treatments. The annotated genes within a Se
treatment were subjected to bioinformatic analysis to gain insight into differences in
the physiological capacities that might result from the separate Se treatments.
Network analysis revealed several common and solely-affected networks. The
common network identified for ISe (ACIN1, GCG, GCLC, GHRH, ITGA2, Mir-222,
MMP9, NPY1R, PDX1) and Mix (ACIN1, CCNB2, CDH4, CXCL2, FCGR2A,
GCLC, ITGA2, MMP9) DEG was cellular movement. The common network
identified for OSe (CNGA1, GCLC, ITGA2, LDHB, LRRTM2, PLCZ1, OPTC, RIN2,
RUFY3, SEPW1, TRPC5, VAMP5, ZNF238) and Mix (EIF4A1, FCGR2A, LALBA,
PLCZ1, OPCT, SEPW1, SHD, TNFAIP8L2, TRPC5, TULP3) was cell-to-cell
signaling and interaction.
No networks were identified solely for OSe treatment. In contrast, the solely
identified networks for ISe were cellular growth and proliferation, DNA replication,
recombination, and repair, cellular movement (CAPRIN2, CEND1, CNGA1,
LRRTM2, NTM, SEPW1, SHD, THOC5, ZNF703) and organ development,
carbohydrate metabolism, tissue development (CDH4, CEP350, GCM1, LALBA,
Mir-222, OPCT, SNAPIN, TRPC5, THG1L). For the Mix treatment, solely identified
networks were cardiac proliferation, cardiovascular system development and function,
cellular growth and proliferation (CEP350, CNGA1, FRAS1, GOLGA3, HBE1, IRX4,
LEPRE1, MTMR2, PSME4, SNAPIN).
Hierarchical Clustering of GeneChips into Se Treatment-specific Groups
Hierarchical cluster analysis of the 139 DEG (Figure 4) revealed four distinct
GeneChip clusters (9 GeneChips each) that were segregated by Se treatment and that
were consistent with the PCA results. Specfically, OSe treatment GeneChips were
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more closely aligned with Control GeneChips than were Mix GeneChips, and the ISe
cluster was similar to Mix GeneChips and most dis-similar to Control GeneChips.
Bioinformatic Analysis of Clustered DEG
Hierarchical clustering of the 139 DEG also identified 8 patterns of gene
expression that were sensitive to Se-treatment (Figure 4).To identify potential
metabolic relationships among DEG within a cluster in Table 1, bioinformatics
analysis was conducted on annotated DEG within a cluster. The predominant (the
highest ratio of DEG to all molecules) networks were identified: Cluster 1, organismal
disease (SEPW1) and molecular and mineral transport (TRPC5); Cluster 2, cell to cell
signaling and interaction (PCDHB14, RUFY3); Cluster 3, tissue development and
protein synthesis (CCNB2, CXCL2, DDHD1, GCG, MTMR2, PSME4, SNHG3RCC1, RIN2); Cluster 4, cell cycle (GSG2) and tissue development (QPCT, MFI2);
Cluster 5, cell movement development (CDH4, CEND1, CNGA1, ITGA2, LALBA,
MMP9, NTM, PCDHA2, SHD, ABO) and interaction (FGF22); Cluster 6, regulation
of hormone (GHRH, Mir-222, PDX1) and skeletal disorders (FBXL13); Cluster 7,
cellular function (LDHB, LRRTM2, PLCZ2, TNFAIP8L2, VAMP5, FRAS1) and
developmental disorder (FRAS1); Cluster 8, cell signaling, molecular and mineral
transport, and metabolism (ACIN1, FCGR2A, GOLGA3, LEPRE1, NPY1R,
SNAPIN, SRP72, ZNF236, THG1L, THOC5) cell growth and tissue function
(THG1L, ZNF22) DNA replication repair (ANDP2).
Differentially Expressed MicroRNA (MiRNA)
Six hundred twenty-one miRNA are detectable by the bovine GeneChip used
for this study. Of these, 621 were expressed, but only three MiRNA (MiR-222, Mir2393, Mir-2300b) were identified among the 139 DEG (Table 1). Among the
remaining annotated DEG, 1 putative mRNA target was identified for Mir-222, 20 for
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Mir-2393, and 9 for Mir-2300b (Table 2). Among these mRNA targets, DDHD1 is
common to both Mir-222 and Mir-2393, whereas RUFY3, LRRTM2, FRAS1 are
common targets of both Mir-2393 and Mir-2300b.
Bioinformatics analysis of the mRNA targets of each differentially expressed
MiR was conducted to identify potential physiological consequences of Se treatment
alteration of MiR expression (Table 2). Whereas MiR-222 is predicted to affect only
one network, the 17 of the 20 differentially-expressed targets of MiR-2393 are
associated with 6 networks, the most prominent (9 mRNA) being Cell Cycle, Cancer,
and Neurological Disease. For MiR2300b, 7 of 9 putative target mRNA are identified
with 4 networks, the most prominent (4 mRNA) being Cell Cycle, Cellular Assembly
and Organization, DNA Repair Replication, Recombination, and Repair.

DISCUSSION
Experimental Model
Little is known regarding the relationship between Se concentrations in the
liver and liver gene expression, especially in cattle. The effect of Se supplementation
on liver gene expression using a Se-deficient versus Se-supplemented experimental
model in rats (Fischer et al., 2001) and chicks (Huang et al., 2011; Sun et al., 2011)
have been reported. However, because most cow-calf operations in regions of Se-poor
soils provide enough Se in diets to avoid Se deficiency. the goal of this research was
to determine the effects of three Se supplementation strategies (ISe, Mix, OSe) on
liver gene expression profiles using a Se-adequate experimental model.
Descriptions of the experimental model, diets, and liver tissue collection, and
Se content in the liver samples used for this trial have been published (Brennan et al.,
2011). However, briefly, liver Se content (μg/g) for Control (0.08 mg Se/day) group
was essentially stable throughout the trial, whereas the Se concentration in ISe, OSe,
44

and Mix heifers increased to about 56 to 112 days and then were stable for the
remainder of the trial (Figure 5, Brennan etal., 2011). The total daily Se consumption
by individual heifers of the Control, ISe, Mix, and OSe treatment groups was 0.82,
3.80, 3.69, and 3.76 mg/day, respectively. The liver Se concentration (µg/g) of these
heifers at day 168 were 0.24 (Control), 0.40 (ISe), 0.49 (Mix), and 0.49 (OSe) and
differed (OSe = Mix > ISE > Control) (Brennan et al., 2011). For the Control, ISe,
and OSe treatments, these Se concentrations levels are consistent with those found in
the previous pilot trial (Liao et al., 2010), which had liver Se concentrations (μg/g) of
0.26, 0.34, and 0.47, respectively, from maturing Angus-cross heifers consuming 0.48,
3.48, and 3.48 mg Se/day for 105 – 106 days (Liao et al., 2010). Importantly, Se
concentrations of 0.25 to 0.50 µg/g in liver tissue are considered normal (Ullrey, 1987;
Corah, 1996; Surei, 2006). Thus, the animal model used for both the present (and pilot)
trial is robust with respect to both Se-adequatecy and Se form-dependent Se
assimilation by liver tissue.
Se Assimilation Levels and Gene Expression Profiles
As just described, Se treatments affected liver Se assimilation by heifers.
Microarray analysis was used to determine the effect of Se treatment on gene
expression (relative mRNA and miRNA levels) and, by extension, Se treatmentinduced differences in physiological capacities. Microarray analysis revealed clear
differences in the hepatic gene expression profiles of the four Se treatment groups
(Figure 4). However, inter-treatment differences in Se content did not match
differences in gene expression profiles. That is, although ISe-induced hepatic Se
concentrations were more similar to Control concentrations, ISe-induced hepatic gene
expression profiles were most different from Control profiles. Likewise, although the
hepatic content of Se in Mix and OSe treatments were essentially identical, OSe
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expression profiles were more similar to Control, and Mix to ISE (Figure 4). Thus,
absolute hepatic Se assimilation was not a good indicator of gene expression. Instead,
the form of Se consumed may be a better indicator. That is, the pattern of hepatic
DEG was most similar between the treatments with the greatest proportion of organic
Se (Control, lowest hepatic Se content) and OSe (one of the highest Se content), while
the hepatic DEG expression profiles were similar between those animals consuming
proportionately increasing amounts of inorganic sources of Se (Mix and ISe).
Therefore, it appears that the form of Se consumed may be more important than the
amount of Se assimilated. Based on this conclusion, future trials should assess the
relationship between total Se assimilation, the form of Se assimilated, and patterns of
gene expression.
Common and Differential Selenium Form-Induced Metabolic Pathways
Because the metabolic fates and pathways for OSe (SeCys, SeMet) and ISe
(selenite) have distinctive, as well as common, components (Figure 6), an unexpected
finding of this study was that the expression of only a few of the genes endcoding
proteins responsible for Se-specific metabolism were altered. Athough expression of
mRNA for 16 of 20 of Figure 6 proteins were detected by the GeneChips (data not
shown), none of these were altered by Se-supplemental treatment. Assuming that Se
might be limiting in non-supplemental heifers, these findings are somewhat
unexpected given that supplementation of organic Se should result in proportionately
greater amounts of SeCys to incorporate into the “regulated” selenoprotein synthesis
pathway (tRNASec-mediated incorporation of SeCys into “selenoprotein” polypeptide
chains), the “unregulated” pathway (non-specific competition between Met and
SeMet binding by tRNAMet and incorporation into “Se-containing proteins”), and the
trans-selenation pathway (Figure 6, Suzuki, 2005). In contrast, with the exception of
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minor amounts of organic Se compounds contained in Se-assimilating ruminant
microbes, inorganic dietary Se will not be metabolized through the the regulated
pathway and its associated recycling capacity. However, the findings from this study
indicate that the non-supplemental Control treatment expressed adequate amounts of
these proteins and, thus, supports the understanding that our animal model (slowgrowing, maturing beef heifer) is one of Se adequency, not deficiency.
Twenty-three of the 25 known mammalian selenoproteins (all but SEP15 and
SEPN) were assayed by the microarray. Of these, only expression of SEPW1 was
altered (Table 1). These results indicate that precursors and enzymes responsible for
SeCys formation and incorporation into polypeptide chains were not lacking in nonsupplemented Control heifers. The upregulation of SEPW1 mRNA expression is
consistent with this genes’ known sensitivity to supplemental Se. In this regard, the
upregulation of SEPW1 mRNA indicates that the model was capable of responding to
dietary Se supplementation.
Functional Analysis of Heiarchial Clusters
The hierarchical clustering of 139 DEG identified 8 patterns of gene
expression that were sensitive to supplemental Se-treatment (Figure 4). Functional
analysis was performed on the annotated DEG within each cluster to gain insight into
the potential physiological significance of these responses. Eight transcripts from
Cluster 1 are involved in cation transport and antioxidative activity. SEPW1
(selenoprotein W-1) contains SeCys, encoded by the UGA codon. SEPW1 belongs to
the selenoprotein W subfamily, of the selenoprotein WTH family, and functions as an
antioxidant enzyme. Specifically, SEPW1 binds to glutathione which targets reactive
oxygen species such as hydrogen peroxide, superoxide anion radical, and hydroxyl
radical, which are toxic by-products of cellular oxygen metabolism (Jeong et al.,
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2002). The binding sites are thought to be SeCys13 and Cys37 residues (Jeong et al.,
2002). Homologues of transient receptor potential (TRP) genes encode a variety of
cation channels, most of which conduct Ca2+ across the plasma membrane (Mori et al.,
2011).
Transient receptor potential (TRP) channels play pivotal roles in sensing and
adapting to a wide variety of environmental changes (Yamamoto et al., 2010).
Immunolocalization studies have revealed that TRPC5 is distributed on both the
apical and basal membrane in the endothelial cell layer of vascular tissue. TRPC5
channels are activated by nitric oxide and inflammatory mediators via oxidative (Snitrosylation) modification of cysteine residues, which triggers the Ca 2+ influx and
other adaptation reactions after sensing the oxidative stress. This study found that the
TRPC5 expression is equally stimulated by all forms of Se supplement. Thus, if
mRNA levels represent functional capacity, then Se supplementation induced an
increased capacity to respond to oxidative stress in Se-supplemented heifers versus
the Se-adequate, but non-supplemented Control heifers.
The cell-to-cell signaling was one pathway that indentified in Cluster 2 DEG.
PCDHB14 expression was increased 1.28- to 1.35-fold by ISe and Mix treatments,
respectively. In contrast, CYP2D14 and RUY3 expression were decreased by OSe.
PCDHB14 is a cadherin protein that belongs to the protocadherin family. As such,
PCDHB14 likely is involved in the modulation of synaptic transmission and the
generation of specific synaptic connections (Frank and Kemler 2002). The upregulation of PCDHB14 by Mix and OSe Se treatments indicates a more active
synaptic signal transmission.
Cluster 3 DEG are involved in tissue development and protein synthesis. The
Mix treatment up-regulated 13 of 15 genes in this cluster, whereas ISE downregulated
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the gene for glucagon (GCG) and OSe downregulated RIN2. DDHD1 can generate
the arachidonic acid-containing lysophosphatidylinositol that increases both the
phosphorylation of the extracellular signal-regulated kinase (ERK) and intracellular
Ca2+ levels (Yamashita et al., 2010). SNHG3-RCC1 is the regulator of chromatin
condensation 1 that was the guanine nucleotide-exchange factor for the Ran GRPase,
and functions as the nucleo-cytoplasmic transport, mitosis, and nuclear-envelop
assembly. RCC1 has a propeller-like structure, one side binds to Ran, and the other
side binds chromatin. Upon some post-translation modification, SNHG3- RCC1 can
generate the RanGTP that is required for spindle assembly and chromosome
segregation during the mitosis (Kline-Smith and Walczak, 2004).
The pattern for Cluster 4 DEG senstivitiy to Se treatments was downregulation (-1.16- to -1.65-fold), with the exception of MF12, which was upregulated
(1.07-fold) by ISe treatment. GSG2 was down-regulated 1.23-fold by OSe treatment.
GSG2 is involved in the chromatin modification especially the histone
phosphorylation, which provides a chromatin binding site for chromosomal passenger
complex at centromeres to regulate chromosome segregation during the mitosis
(Wang et al., 2011). ZNF238 (Zinc Finger 238; RP58) also is a DNA binding protein
and acts to repress transcription, likely by binding the Dnmt3a DNA
methyltransferase. ZNF238 is a member of the POZ-zinc finger family (Okado et al.,
2009), which are important regulators of DNA damage responses, cell-cycle
progression, and many developmental events (Kelly and Daniel, 2006).Of the Cluster
4 DEG, MiR2393 was the most affected, being significantly downregulated 1.41- to
1.65-fold by Mix and OSE, and quantitatively down-regulated by ISe, respectively.
As with ZNF238, Mir2393 acts to repress expression but by binding mRNA rather
than DNA (see below).
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Similar to MiR2392, QPCT (glutaminyl-peptide cyclotransferease or
glutaminyl cyclase) mRNA expression also was affected by all 3 Se treatments, being
downregulated by 1.16-, 1.26-, and 1.30-fold by ISe, Mix, and OSe, respectively.
QPCT is involved in the synthesis of pyroglutamyl peptides by posttranslational
cleavage of nascent gene products to their respective N-terminal pyroglutamyl
bioactive peptides, including thyroid-releasing hormone, gonadotrphophin-releasing
hormone, and corticotrophin-releasing hormone (Fischer and Spiess, 1987). However,
paradoxically, QPCT mRNA was not detected by a previous Northern blot analysis
(Pohl et al., 1991), although strong expression in pituitary and most brain regions, and
relatively, lesser expression by retina, kidney, thymus, and skeletal muscle. Thus,
either our microarray detection of bovine QPTC mRNA expression by hepatoctytes
was more sensitive then Northern blot analysis, or differences in liver tissue samples
assayed existed (slaughterhouse tissue versus animals of known origin). If our liver
expression of QPTC is validated, then an important finding from this study is that Se
supplementation may alter QPTC-mediated metabolism, most auspiciously (perhaps)
that occurring in the pituitary.
Cluster 5 DEG genes were up-regulated by any form of supplemental Se
relative to Control. The predominant network of Cluster 5 was cell movement
development. CDH4 is a calcium-dependent cell-cell adhesion glycoprotein, that is
comprised of cadherin repeats and that is important for tissue development. The
CNGA1 encoded protein in plasma membrane increases translocation of Ca 2+ and Na+
in extracellular space to Ca2+ in cytoplasm (Kaupp and Seifert, 2002). THOC5 78 kd
FMIP protein decreases differentiation of macrophages (Tamura et al., 1999) and it is
involved in the differentiation of monocytes (Carney et al., 2009) and can increase the
differentiation of granulocytes.
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ITGA2 encodes the alpha-chain of integrins found in T cells, fibroblasts, and
is involved with cell adhesion and cell-surface mediated signaling. Importantly, the
integrin complex can mediate the activation of hepatic stellate cells (Friedman, 2000).
ITGA2 upregulation indicates greater capacity for healing and IL-3 mediated immune
respose. ITGA2 also is involved in activation of monocyte upon to trigger monocyte
migration to inflammatory sites to regulate IL-13-mediated monocyte activation
(Yakubenko et al., 2011). The expression of ITGA2 mRNA was upregulated equally
(1.22- to 1.34-fold) by all 3 Se treatments. The upregulation of it for Se treatment
indicates better tissue wound healing capacity in response to injury, and also indicates
an increased activation of macrophages.
Although not identified as part of the cell movement development network by
IPA analysis, GJB4 is a transmembrane connexin protein that forms gap junctions.
Gap junctions provide for a unique system of intercellular communication allowing
rapid transport of small molecules from cell to cell (Cancelas et al., 2000). GJB4 is
expressed by the liver cobblestone area-forming cells and is responsible for the
communication and supportive ability and GJB4-dependent gap junction can
contribute to the regulation of the clonal outgrowth of hematopoietic progenitors
(Cancelas et al., 2000). It also reported that GJB4 deficiency impairs hemopoiesis and
the GJB4 knockout fetuses have a lower content of progenitor and stem cells in their
liver as compared with their wt littermates. Besides, the GJB4 may participate in the
function of B and T lymphocytes and macrophages thus influence the body immune
function (Alves et al., 1996; Alves et al., 1998). GJB4 mRNA expression was
upregulated 1.13- and 1.26-fold by ISe and Mix treatments, respectively, and tended
to be upregulated (1.10-fold) by OSe treatment. This upregulation suggests that
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heifers consuming inorganic and mixed forms of Se had greater capacities for hepatic
GJB4-mediated cell-to-cell communication and immune system function.
SLC6A17 is a glutamatergic- and GABA- (somewhat) specific neuron
transporter responsible for Na+-dependent absorption of (primarily) glutamine and
proline from the cytosol into synaptic vesicles (Zaia and Reimer, 2009). In liver tissue,
SLC6A17 was equally upregulated by ISe and Mix. If the bovine expression pattern
for SLC6A17 is the same for other species, then this finding indicates the the
glutamatergic neurons which innervate the liver have an increased neural propagation
function, due to the increased capacity to absorb the precursor for glutamate,
glutamine.
For Cluster 6 DEG, ISe treatment increased gene expression for 8 of 11
annotated DEG, whereas Mix decreased expression of 3 genes and OSe had no effect.
The predominant network found for Cluster 6 genes was regulation of hormone
metabolism (GHRH, PDX1). GHRH is known to stimulate NF-kappa beta
transcription factor that activates angiogenic factor and expression of genes involved
in encoding enzymes in the prostaglandin-synthesis pathway (NCBI,
http://www.ncbi.nlm.nih.gov). The transcriptional factor pancreatic duodenal
homeobox 1 (PDX1) plays a pivotal role in pancreatic beta-cell differentiation, and
insulin gene expression and synthesis (German et al., 1995; Offield et al., 1996;
Ahlgren et al., 1998; Bernal-Mizrachi, et al., 2001). We found PDX1 mRNA was
upregulated 1.17-fold by ISe but not affected by Mix or OSE treatments. Although it
has been demonstrated that PDX expression can be increased through
hyperacetylation of H3 and H4 histones of the Pdx1 promoter in response to
overexpression of Se-dependent cellular glutathione peroxidase-1 (GPX1) (Wang et
al., 2008), GPX1 expression was not affected by Se treatment (data not shown).
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Therefore, whether PDX1 expression was induced directly by increased inorganic
concentrations due to ISe treatment effects, indirectly through post-transcriptional
effects on GPX1, or by a different mechanism, remains to be determined.
Of the 10 DEG in Cluster 7, 2 (LDHB, VAMP5), were upregulated by OSe
treatment whearas 6 were down regulated by ISe treatment, 1 by ISe or Mix, and 1 by
Mix alone. Genes in Cluster 7 are involved in the membrane adhesion (FRAS1),
immune function (TNFAIP8L2), and glycolysis (LDHB) networks.
The effect of Se treatment on Cluster 8 genes was similar to that of Cluster 7
genes; OSe increased expression of 5 of 20 genes in Cluste 8, whereas ISe (5), ISe
and Mix (6), or Mix alone (4) decreased expression of DEG. These DEG are involved
in cell signaling, molecular and mineral transport, and tissue growth and function.
Cluster 8 also contained two of the most strongly affected DEG in the trial.
Bos taurus major histocompatibility complex, class II, DQ alpha 2 (BOLA-DQA2;
Morooka et al., 1995) BOLA-DQA2 mRNA expression was increased 2.67-fold by
OSe, but was not affected by ISe or Mix treatments. This finding suggests that OSeconsuming animals may have a greater capacity to respond to pathogen challenges
(Handunnetthi et al., 2009; Hou et al., 2012) assuming that OSe heifers were not
stimulated by a pathogen challenge not present to the other treatment groups. The
additional understanding that Control (0.08 mg Se/day from diet) and Mix (diet plus
1.5 mg supplemental OSe) treatments failed to stimulate BOLA-DQA expression
suggests that a threshold amount of supplemental OSe is required that exceeds 1.58
mg of organic Se/day in organic forms.
In contrast to BOLA-DQA2, expression of CEP350 (centromere protein
350kDa) was decreased 1.5- and 1.39-fold by ISe and Mix, respectively. CPE350
(Zimin et al., 2009) is localized to the centrosome and thought to be involved with the
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regulation of nuclear hormone receptor function. However, the physiological
relevance of decreased CEP 350 expression is not obvious.
Neuropeptide Y is one of the most abundant neuropeptides in the mammalian
nervous system and exhibits effects on psychomotor activity, food intake, regulation
of central endocrine secretion, and potent vasoactive effects. NPY is found in the liver
and can regulate blood flow in, and secretion by, the liver (Ding et al., 1991; El-Salhy,
2000). The receptor for NPY (NPY1R) is expressed by the liver and is associated with
glycoprotein processes. Hepatic production of the glycoprotein hormone, which
regulates production of bone marrow platelets (http://reviewcenter.net/metabolism/liver-metabolism- pathways-and-its-disorders/) and several
other glycoproteins, is expressed in fibrotic livers (Li and Friedman, 1999; Tsukada et
al., 2006). Aspartate aminotransferase and alanine aminotransferase are hepatic
biomarkers associated with NPY1R copy number variation (Kim et al., 2010). That
NPY1R was downregulated (1.32-fold) by ISe, but unaffected by Mix or OSE
treatments, suggests a decreased regulation of glycoproteins and glycoprotein
hormone in liver tissue of ISe heifers.
The SANPIN is a SNAP-associated protein, and a component of the SNARE
complex of proteins that is required for synaptic vesicle docking and fusion (Ilardi et
al., 1999). SNAPIN is involved with synaptic vesicle maturation (Pan et al., 2009) and
induces synaptic transmission after binding of synaptic vesicles (Ilardi et al., 1999).
SNAPIN expression was down-regulated by ISe (1.14-fold) and Mix (1.19-fold), but
not by OSe. Thus, ostensibly, heifers consuming ISe or Mix forms of Se would have
impaired synaptic transmission capacity relative to Control and OSe heifers, animals
consuming only organic forms of Se.
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Relationship between DEG and MiRNA expression
The expression of 621 miRNA was detected by miRNA analysis (data not
shown). Of these, the expression of three (MiR222, MiR2393, MiR2300b) were
affected by Se supplementation treatment. Whereas the expression of MiR222 has
been reported in other species, but the expression of MiR2393 and Mir2300b is
unique to bovines.
MiR222 (Cluster 6) was up-regulated (1.23-fold) by ISe treatment, but not by
the other treatments. Because upregulation of MiR are associated with decreased gene
expression, this result suggests that ISe treatment has a negative effect on genes
controlled by MiR222. Of the 85 annotated DEG, only seven (GCG, glucagon from
Cluster 3; NPY1R, TMEM168, THG1L, THOC5, ADNP2, from Cluster 8) shared
this pattern of ISe-induced decreased expression (Table 1). However, none of these
are putative targets of MiR222. Instead, only DDHD1 is a putative target (Table 2).
However, DDHD1 expression was up-regulated 1.30 fold by Mix treatment (Table 1).
Thus, (a) DDHD1 was not a target of MiR222 and (b) the consequence of MiR22
upregulation by Mix Se treatment is not obvious.
In contrast to MiR222, MiR2393 expression was decreased by Se treatment,
thus its inhibitory effect of target mRNA would be to increase their expression.
Specifically, MIR 2393 (Cluster 4) expression tended to be downregulated (1.20-fold)
by ISe and was downregulated by Mix (1.41-fold) and OSe (1.65-fold) (Table 1).
However, of the 17 putative targets of MiR2393 (Table 2), one of these, QPCT, was
in the same cluster (Cluster 4, any form of Se supplement down regulated DEG as
MiR2393 (Table 1). Therefore, QPCT does not appear to be a target of MiR2393.
As for MiR222, DDHD1 also is a target of MiR2393. Unlike MiR222,
MiR2393 was downregulated by Mix treatment concomitant with an upregulation of
DDHD1. Thus, the data are consistent with DDHD1 expression being regulated by
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Mix treatment downregulation of MiR2393, as opposed to regulation by MiR222.
DDHD1 can generate the arachidonic acid-containing lysophosphatidylinositol that
increases both the phosphorylation of the extracellular signal-regulated kinase (ERK)
and intracellular Ca2+ levels (Yamashita et al., 2010). TRP5C also is a putative target
of MiR2393 whose expression was upregulated by ISe (1.37-fold), Mix (1.58-fold),
and OSe (1.67-fold). As noted before, TRP5C (Cluster 1) expression increases the
capacity for Ca2+ influx into cells (Mori et al., 2011). Together, the concomitant
downregulation of MiR2393 and upregulation of DDHD1 and TRP5C by at least Mix
and OSe supplementation suggests one mechanism by which Se supplementation of
Se-adequate diets results in increased redox potential (Yamamoto et al., 2010). This
supposition is strengthened by the observation that SEPW1 (Cluster 1), which
functions as an antioxidant enzyme (Jeong et al., 2002), also is upregulated by all
three Se supplements (Table 1).
As for MiR2300b, the effect of Se supplementation on liver expression of
MiR2300b was to decrease it (Table 1). Thus, the expression of MiR2300b targets
should be increased. Unlike MiR2393, however, MiR2300b was down-regulated by
ISe (1.25-fold) and Mix (1.37-fold) treatment, not OSe and Mix. Of the putative seven
DEG MiR2300b targets (Table 2), four (FRASI, RUFY3, SNAPIN, THG1L) were
downregulated by Se treatment and thus not likely regulated by MiR2300b expression.
Of the remaining three putative targets, LRRTM2 is upregulated by ISe and OSe,
SNHG3-RCC1 is upregulated by Mix, and SEPW1 is upregulated by all three Se
supplement forms. Thus, the expression patterns of none of DEG that are putative
targets of MiR2300b match those of MiR2300b, as would be expected in their
expression was regulated by MiR2300b.
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Predominant Se Treatment-specific Effects on Gene Expression
Although heiarchial clustering of the 139 DEG resulted in the identification of
eight different gene expression clusters, consideration of the Se treatment effects on
only the 85 annotated DEG (Table 1) reveal four prominent, Se form-induced
expression patterns. First, from Clusters 1 (3 genes) and 5 (15 genes), any Se form
supplement (ISe, Mix, OSe) increased gene expression relative to Control. Second, in
Cluster 3 (15 genes), it is apparent that the Mix treatment upregulates gene expression,
whereas OSe or ISe downregulates gene expression. Third, from Cluster 6 (11 genes),
whereas OSe does not affect expression, ISe treatment upregulates gene expression
and Mix treatment downregulates expression. Fourth, from Clusters 7 (10 genes) and
8 (20 genes) either Mix or ISe treatments downregulate gene expression whereas OSe
upregulates expression.
In addition, two other Se form-induced patterns are represented in the gene
clusters, but the relative few genes involved with each cluster reduce confidence in
their validity. Specifically, from Cluster 2 (3 genes) it would appear that whereas OSe
upregulates gene expression, ISe or Mix decreased expression. In contrast, from
Cluster 4 (5 genes), whereas one gene is downregulated by all three Se treatments,
three others are downregulated by OSe or Mix, but another is upregulated by only ISe
treatment.
Comparison of Current to Previous Studies on the Effect of Dietary Se form on
Hepatic Gene Expression in Developing Beef Heifers.
Previously, we found that dietary supplementation of none or 3 mg Se/day as
ISe or OSe to maturing beef heifers (Liao et al., 2010) altered the expression of about
80 mRNA. Of these, only one DEG (LEPRE1, leucine proline-enriched proteoglycan
(leprecan) 1) was found altered by Se supplementation (ISe, OSe) in both experiments.
However, in the Liao et al. (2010) trial, LEPRE1 was upregulated by ISe (1.53-fold)
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and OSe (1.47-fold) treatments (Mix treatment was not tested), whereas in the present
trial, LEPRE1 was not affected by ISe or OSe treatment but was downrregulated
(1.15-fold) by Mix treatment (which was not used in the Liao et al. (2010) trial).
At first glance, it seems surprising that more similarities were not found
between the two studies given that the same experimental model was used. However,
upon further consideration, the lack of similaritiy between gene expression induced by
ISe and OSe treatments in the pilot (liao et al., 2010) versus current trial may be
reasonable given the following differences: (1) although similar in magnitude, Se
concentrations in liver after 105/106 days of supplementation (Liao et al., 2010) may
not have been stable, as they were after 168 days (current trial), (2) different
experimental designs were used (non-supplemented Control, ISe, and OSe and n
=6/treatment for Liao et al., 2010 versus non-supplemented Control, ISe, OSe, and
Mix, n = 9/treatment for the present study), (3) differences in the microarray assays to
detect gene expression due to the use of different GeneChips, and (4) a combination
of the above. With regard to the third possibility, Liao et al. (2010) used the
commercially-available Affymetrix GeneChip Bovine Genome Array, with its 24,016
gene transcripts, and annotated using NetAffix annotation database for 3’ IVT
Expression on Bovine GeneChip Array 3’-weighted coverage of transcripts
(http://www.affymetrix.com/analysis/index:affx, Affymetrix, Inc.). In contrast, the
present trial used the custom WT Btau 4.0 Array (version 1), which contained 26,303
gene transcripts, a complete 5’ to 3’ coverage of gene transcripts, and annotation
based on an updated draft (4.0) of the Bovine Genome. Of note, the Btau 4.0
GeneChip used in the current study contained 621 microRNA, whereas the
Affymetrix GeneChip Bovine Genome Array contained none.
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SUMMARY
The expression pattern of these affected genes appeared to be more similar for
Control and OSe than Control and ISe, and Mix is between OSe and ISe. This result
would suggest that the different gene expression profile of OSe, Mix, ISe heifers, was
not caused by an inter-form gradient (0, 50, 100% ISe or OSe) effect, but by their
biochemical form and form-specific metabolic pathways.
The affected genes were grouped into eight distinct clusters. Functional
analysis of these affected genes by cluster showed that they are associated with
different physiological functions, including (1) nutrient metabolism, (2) molecular
and mineral transport, (3) cell signaling and interaction, (4) cellular growth,
proliferation, (5) immune response and hormone regulation, and (6) tissue/organ
development and function. This result would gain a more complete perspective of
how different dietary forms of Se caused the specific hepatic transcripts expression
and biofunctions profile changed. Regarding the effect of the supplemental Se forms,
eight distinct groups of genes were identified: those (1) commonly affected by ISe
and OSe supplementation, (2) commonly affected by ISe and Mix supplementation, (3)
commonly affected by OSe and Mix supplementation, (4) commonly affected by ISe,
OSe, and Mix supplementation, (5) solely affected by ISe supplementation, (6) solely
affected by OSe supplementation, (7) solely affected by Mix supplementation, (8)
affected by ISe, Mix, or OSe supplementation but not differ from Control.
In addition, the result of the miRNA analysis indicates the possible
relationship of the changed hepatic gene expression and biofunctions with the
differentially up- or down- regulation of microRNAs caused by different Se
supplementation. The true nature of these relationships would still require more
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research to fully understand exactly how these microRNAs affect their targets
expression.

CONCLUSION
The objectives of the current work were to (1) compare hepatic gene
transcriptome profiles when hepatic liver assimilation was stable (d 168) using
microarray methods, and (2) conduct bioinformatics analysis of these profiles to
predict altered hepatic physiological capacities induced by specific forms of Se
supplement.
Hepatic gene transcriptome profiles were successfully compared, resulting in
the understanding that the chemical form (inorganic, organic, mix) of supplemental Se
differentially affected hepatic gene expression of growing heifers after 168d
supplementation. The bioinformatics analysis results indicated that Se treatments
induced differentially expressed hepatic genes could be grouped into several clusters
upon their expression pattern, and the genes in each cluster are indicative of
differentially changed biofunctions. In addition, the putative target mRNAs of Se
treatment induced differentially expressed miRNA could influence different
biofunctions, but more work needs to be done to validate these findings.
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Table 1. Hepatic gene transcripts affected by dietary selenium (Se) supplementation treatment for 168 days to growing beef
heifers transcripts
Dietary Se treatments2
Gene Symbol3

Gene Description

Control

ISe

Mix

OSe

SEM4

P-value5

12907339

TRPC5

1.00000a

1.36791b

1.58006b

1.66591b

0.12907

0.002725

12697969

LOC100139773

transient receptor potential cation channel, subfamily C,
member 5
hypothetical LOC100139773

1.00000a

1.15171a,b

1.36042b

1.27082b

0.08467

0.006423

1.00000

a

-1.03848

a

1.05093

a

1.24424

b

0.07294

0.006400

a,b

-1.28400

b

1.39857

a

1.44240

a

Transcript ID
Cluster 1

12697805

LOC786881

similar to hCG1812167

12675620

---Intron

---

1.00000

0.18484

0.006020

12914697

LOC100336032

1.00000a

1.15312a,b

1.13500a

1.33547b

0.07299

0.005211

12752300

SEPW1

PREDICTED: Bos taurus hypothetical protein
LOC100336032
selenoprotein W, 1

1.00000a

1.22275b

1.21631b

1.26013b

0.05227

0.000289

a

a

b

1.00664

1.08321

a,b

12710910

NEK5

NIMA (never in mitosis gene a)-related kinase 5

1.00000

0.04425

0.007897

12677772

---Intron

---

1.00000a

1.11436a

1.22302a

1.15446

1.60125b

0.12704

0.006116

12914839

LOC100336100

1.00000a

1.15229b

1.18140b

1.03912a

0.04393

0.001174

12881728

PCDHB14

PREDICTED: Bos taurus hypothetical protein
LOC100336100
protocadherin beta 14

1.00000a

1.28212b

1.34957b

1.06088a

1.15627

a

1.09450

a

1.02846

a

1.06498

a

Cluster 2
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12864124

CYP2D14

cytochrome P450, family 2, subfamily D, polypeptide 6

1.00000

a,b
a

0.09183

0.006410

-1.20399

b

0.08664

0.007010

-1.16205

b

12871032

RUFY3

RUN and FYVE domain containing 3

1.00000

0.05771

0.005646

12764375

LOC532807

similar to RUN and FYVE domain containing 3

1.00000a

1.09947a,b

1.15836b

-1.09996a

0.06654

0.008889

MGC134040

hypothetical protein MGC134040

1.00000a

-1.03393a

1.17224b

-1.06679a

0.06037

0.005824

a

a

b

a

0.11938

0.003537

-1.16518a

0.11918

0.005328

-1.06086

a,b

0.03330

0.001132

0.09570

0.007251

0.04733

0.002060

0.03869

0.000243

0.07236

0.000661

Cluster 3
12847828
12869909

CXCL2

chemokine (C-X-C motif) ligand 2

1.00000

12693465

CCNB2

cyclin B2

1.00000a

-1.06124a

1.34891b

glucagon

1.00000

a

b

1.04313

a

1.00000

a

1.33732

b

-1.00647

a

a

1.17588

b

-1.02677

a

1.07856a

12774328
12699461

GCG
PFN4

profilin family, member 4

-1.03514

-1.09897
1.20285

a,b

1.03334

a

1.38450

12786583

IRX4

iroquois homeobox 4

1.00000

12826590

LOC531024

similar to olfactory receptor 1200

1.00000a

1.06087a

1.21436b

a

b

b

12686044

LOC537248

similar to ACPL2 protein

1.00000

1.19225

1.35993

-1.13931

1.05331

a,b

Table 1. (Continued)
12687785
12716554
12782928

RNASE12
RIN2
SNHG3-RCC1

hypothetical protein LOC100297737
Ras and Rab interactor 2
SNHG3-RCC1 readthrough transcript

1.00000a

-1.01829a

1.42337b

-1.05685a

0.08304

0.000151

1.00000

a

a

1.09313

a

b

0.05574

0.001630

1.00000

a

1.15455

b

1.02993

a,b

0.04166

0.009548

a

1.32674

b

1.10323

a,b

-1.00644
1.07997

a,b

1.13081

a,b

-1.15966

12827960

PLAC9

placenta-specific 9

1.00000

0.05955

0.000667

12900046

LOC510904

hypothetical LOC510904

1.00000a

1.32197b

1.33335b

1.23397b

0.08776

0.006865

1.00000

a

a

1.32775

b

1.08349

a

0.07614

0.007144

1.00000

a,b

1.09178

c

1.03129

b

0.02711

0.001488

a

1.19114

b

1.00366

a

0.05130

0.003979

1.32247b

0.10309

0.009497

1.09288

a,b

0.11226

0.005933

1.10533

a,b

0.05802

0.007803

1.08275

a

0.05766

0.007762

0.14605

0.005896

0.06566

0.001069

0.15143

0.008101

-1.39136b

0.13136

0.003895

-1.80657

c

0.15769

0.006690

-1.23345

b

0.06242

0.008242

-1.18675

b

0.05684

0.005632

-1.29939b

0.06257

0.001040

-1.65305

c

0.09321

0.000119

-1.17690

b

0.05856

0.008190

-1.10413

a

0.04999

0.009302

12905415
12729265

LOC539973
MTMR2

similar to Zinc finger, DHHC-type containing 3
myotubularin related protein 2

12706499

PSME4

proteasome (prosome, macropain) activator subunit 4

1.00000

12676376

---Intron

---

1.00000a

12803871
12910859

LOC782475
eIf4a1

similar to olfactory receptor 1368
eukaryotic translation initiation factor 4A1

1.08064

-1.02685
1.02009

a

a

1.01106a

1.00000

a

-1.13553

1.00000

a

1.00747

a

a

1.02440

a

1.30861b
a

1.36319

b

1.21265

b

1.21770

b
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12814476

ANKRD61

ankyrin repeat domain 61

1.00000

12677234

---Intron

---

1.00000a

1.26833a

1.71743b

1.12841a

1.00000

a

a

1.29974

b

a

a,c

1.21088

c

12693689
12675450

DDHD1

DDHD domain containing 1

1.04630

-1.43052

b

---Intron

---

1.00000

---Intron

---

1.00000a

---

1.00000

a

-1.28715

a,b

1.00000

a

-1.02219

a

a

a

1.02109

-1.22692

a,b

Cluster 4
12677448
12676664
12765783

---Intron
GSG2

germ cell associated 2 (haspin)

12888519

LOC788287

similar to Olfactory receptor 90

1.00000

12698464

QPCT

glutaminyl-peptide cyclotransferase

1.00000a

12818810
12911831

MIR2393
ZNF238

microRNA mir-2393
Zinc finger 238 (RP58)

12686393

MFI2

12676594

---Intron

antigen p97 (melanoma associated) identified by
monoclonal antigen
---

TTC21A

tetratricopeptide repeat domain 21A

1.13538a

1.03204

-1.37222b

-1.16423b
a,b

-1.38955

b,c

-1.03877

a

-1.04864

a

-1.26451b

1.00000

a

-1.41205

b,c

-1.20463

1.00000

a

1.02814

a

-1.10135

a,b

1.00000

a,b

1.07395

b

-1.06797

a

1.00000a

1.05904a

1.13670a

-1.26234b

0.09904

0.005182

1.00000a

1.21548b

1.01361a

1.02297a

0.06029

0.007711

a

b

0.04810

0.006433

Cluster 5
12796744
12912929

CAPRIN2

caprin family member 2

1.00000

1.13153

-1.02243

a

-1.05430

a

Table 1. (Continued)
12914495
12879404
12873243

LOC516089(discon)
FGF22
CNGA1

PREDICTED: Bos taurus olfactory receptor 78-like
fibroblast growth factor 22
cyclic nucleotide gated channel alpha 1

1.00000a

1.25318b

1.15570b

1.12760b

0.05707

0.004526

1.00000

a

1.29373

b

1.08106

a

1.08686

a

0.07032

0.006865

1.00000

a

1.19197

b

1.13980

b

1.12575

b

0.04591

0.004660

a

1.23641

b

1.20520

b

1.02791

a

12857050

LALBA

lactalbumin, alpha

1.00000

0.06083

0.001969

12705807

ABO

1.00000a

1.22678b

1.10102a,b

1.02565a

0.05988

0.007013

12726472

LOC100300575

ABO blood group (transferase A, alpha 1-3-Nacetylgalactosaminy
similar to olfactory receptor 154

1.00000a

1.25720c

1.20417b,c

1.08372a,b

0.05796

0.002456

1.00000

a

1.18358

b

1.14196

b,c

1.02988a,c

0.05462

0.009475

1.00000

a

1.16689

b

1.02240

a

-1.00409

a

0.04904

0.008942

1.00000

a

1.29932

b

1.16221

b

b

0.05890

0.001454

12807139
12882374

LOC786846
PCDHA2

12911511

ADAM7

12834487

NTM

12786958

ITGA2

12720027

CDH4

63

12691885

LOC614591

similar to olfactory receptor 108
protocadherin alpha 2
Disintegrin and metalloproteinase domain-containing
protein 7-like
neurotrimin
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2
receptor)
cadherin 4, type 1, R-cadherin (retinal)
similar to Olfr736 protein

1.00000a

1.25025b

1.18765b

1.17953b

0.06262

0.007055

a

b

b

b

0.07739

0.004259

1.00000

1.27304

1.22285

1.19777b

1.22550b

1.10903a,b

0.06082

0.009903

1.00000

a

1.31777

b

1.07387

a

a

0.07211

0.001495

a

1.17262

b

1.08239

a,b

0.04312

0.004690

0.07560

0.003120

0.06154

0.003386

LOC531152

similar to solute carrier family 5 (sodium/glucose cotran

1.00000

12687141

LOC781919

hypothetical LOC781919

1.00000a

1.29038b

1.09990a

a

b

b

LRFN4

12693387

LOC100337247

12885640
12843025

SHD
SLC6A17

leucine rich repeat and fibronectin type III domain
containin
hCG1812119-like
Src homology 2 domain containing transforming protein D
solute carrier family 6, member 17

1.00000

1.22073b

-1.02350a

0.09509

0.005659

1.00000

1.17028

1.16044

b

1.07479

a,b

0.04725

0.006491

1.00000

a

1.26507

b

1.23217

b

1.11242

a,b

0.06281

0.002701

a

1.19347

b

1.23236

b

1.07057

a,b

0.05958

0.004127

1.22910b

1.05533a,b

0.05476

0.004287

b

a,b

0.05874

0.002801

1.10493a,b

0.05783

0.003008

1.00666a

0.05158

0.006880

0.05132

0.000338

0.08867

0.004406

hypothetical protein LOC100336642

1.00000

lysozyme G-like 2

1.00000a

GJB4

12910332
12829684
12911453

LOC618023
CEND1
LOC617745

similar to mCG1035526
cell cycle exit and neuronal differentiation 1
PREDICTED: Bos taurus histone cluster 1, H2bd-like

1.07978

b

b

LYG2

12842299

-1.02790a

1.33301b

LOC100336642

matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase,
92k
gap junction protein, beta 4, 30.3kDa

1.20157

1.02624

a

a

12707153

MMP9

1.25464

-1.01174

1.00000a

12906697

12713813

1.33601

1.00000a

12747236

12831279

1.16758

1.00000

a

1.10830a,b
1.24610

b

1.20563

1.00000a

1.13385b

1.26389b

1.00000

a

1.13489

b

1.16805

b

1.00000

a

1.20278

b

1.10631

a,b

1.00000

a

1.33297

b

1.26593

b

1.08945

-1.04940
1.02369

a

a

Table 1. (Continued)
12677810

---Intron

---

1.00000a

1.80027b

1.44397a,b

1.01137a

0.18686

0.007738

---Intron

---

1.00000a

1.25973b

1.04358a

1.23621b

0.07479

0.006589

a

b

b

b

0.07550

0.008159

1.17265b

0.06415

0.005043

1.08987

a,b

0.05729

0.008473

1.05058

a

Cluster 6
12677714
12802414

LOC523769

similar to Olfactory receptor 11A1 (Olfactory receptor OR

1.00000

12741683

LOC100295022

similar to pre-B lymphocyte gene 2

1.00000a,c

12740074
12804717

LOC530749
GCM1

hypothetical LOC530749
glial cells missing homolog 1 (Drosophila)

1.00000

a

1.00000

a
a

1.33145

1.12993a,b

1.17429

1.17281

-1.06419c

1.18507

b

-1.01920

1.20950

b

a

1.04049

a

1.04205

b

12686542

C1H21ORF7

chromosome 21 open reading frame 7 ortholog

1.00000

12906283

MIR222

microRNA mir-222

1.00000a

1.22316b

-1.00025a

1.00000

a

1.14629

b

-1.04146

a

1.00000

a

1.22925

b

-1.00493

a

1.00000

a

1.25359

b

12824553
12730430

ZNF703
LOC788649

12911627

LOC790172

12713247

LOC100196900

zinc finger protein 703
similar to odorant receptor HOR3beta3
PREDICTED: Bos taurus membrane glycoprotein gp140like
hypothetical LOC100196900

0.05657

0.006471
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0.007012

0.06658

0.008782

1.04799

a

0.15558

0.003061

1.02182

a

0.04358

0.001923

1.06376

a

0.08860

0.001017

1.03846a

0.05034

0.003826

1.74958

1.00000

a

1.17319

b

a

1.42674

b

1.06038

-1.11448

-1.10204a
1.04876

a

1.00527

a

1.01118

a

12882371

OR7E24

similar to Olfactory receptor 18 (Olfactory receptor 145-

1.00000

12854700

FBXL13

F-box and leucine-rich repeat protein 13

1.00000a

1.16934b

1.00000

a

1.22927

b

1.00000

a

1.16694

b

-1.02570

a

1.41912

b

a

12682969

LOC100296558

hypothetical protein LOC100296558

1.00000

12674910

---Intron

---

1.00000a

12729575

1.15272

0.04430

1.00000

pancreatic and duodenal homeobox 1

0.008928

1.06022a,b

b

PDX1

0.06580

b,c

0.008923

a

12712598

1.07249

0.07243

1.16389b

growth hormone releasing hormone

0.007012

a

1.00000a

GHRH

0.04940

a

b

1.00000

12717977

1.03012

a

similar to pol protein

similar to protein phosphatase 2, regulatory subuni

0.001913

a

a

tubby like protein 3

LOC100298746

0.006607

0.06853

-1.18405b

LOC782977

12902043

0.05544

-1.09591a

-1.03255

-1.00273a

TULP3

---

0.009211

1.09330a

12876076

PAKD1

1.10068

a,c

0.05491
a

1.00000a

12866241

12913095

-1.16979

a

a

1.35052b
1.07921

a,b

-1.03845a
1.06399

1.15929

a

-1.00427
a

-1.21602a
-1.14303

-1.00561

a

0.06520

0.009874

1.02967

a

0.05157

0.006236

1.08157

a

0.07247

0.000266

1.12980a

0.11494

0.001786

0.06238

0.008809

b

-1.10060

a,b

HBE1

hemoglobin, epsilon 1

1.00000

LDHB

lactate dehydrogenase B

1.00000a

-1.02584a

-1.13592a

1.21088b

0.08583

0.007247

1.00000

a

1.09221

a,b

1.01750

a,b

1.18502b

0.04999

0.008498

1.00000

a

1.20167

b

1.03651

a,b

b

0.08945

0.008903

Cluster 7
12856863
12707574
12906833

VAMP5
LOC100337148

vesicle-associated membrane protein 5 (myobrevin)
nuclear RNA export factor 3-like

1.34291

Table 1. (Continued)
12675356
12844091
12770586

---Intron
TNFAIP8L2
CDRT4

--tumor necrosis factor, alpha-induced protein 8-like 2
CMT1A duplicated region transcript 4

1.00000a

1.10150a

-1.43145b

1.14442a

0.10746

0.000423

1.00000

a

a

-1.10577

b

1.07832

a

0.04659

0.007207

1.00000

a

-1.15988

b

1.06567

a,b

0.06043

0.009912

a

-1.12408

a

1.22693

b

0.09456

0.009437

1.12832b

0.05972

0.005353

-1.24480

b,c

0.09101

0.004356

0.06429

0.002107

0.04580

0.002755

0.06033

0.006992

12676756

---Intron

---

1.00000

12885754

LRRTM2

leucine rich repeat transmembrane neuronal 2

1.00000a

12675362
12678012

---Intron
---Intron

-----

1.00000

a

1.00000

a
a

1.02130

-1.04470
1.13462

a,b

a,b

1.17937b

-1.03318a

-1.15313

a,b

-1.00494

a

-1.06351

a,b

-1.42605

c

-1.26902

b

-1.10875

a

-1.19444

c

-1.13876

b,c

1.01611a

12857735

PLCZ1

phospholipase C, zeta 1

1.00000

12910700

MCART6

similar to mitochondrial carrier triple repeat 6

1.00000a

1.05026a

-1.17399b

1.00000

a

a

-1.17755

b

-1.00326

0.05950

0.009642

1.00000

a

-1.13431

b

1.00502

a

0.04307

0.008158

a

-1.11814

b

1.06801

a

12871908
12895450

FRAS1
SLC35D2

similar to rCG64566
solute carrier family 35, member D2

1.03201

-1.09449

b

-1.03373

a,b

a
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12732657

OR2AT4

similar to olfactory receptor Olr35

1.00000

0.04643

0.007303

12759892

LOC785933

1.00000a

1.01002a,b

-1.14507a

1.15762b

0.06967

0.004500

12914365

LOC100462699

similar to Orphan sodium- and chloride-dependent
neurotra
---

1.00000a,b

1.23788b

-1.26864a

1.13590b

0.11736

0.004271

BOLA-DQA2

Bos taurus major histocompatibility complex, class II

1.00000a

-1.30149a

-1.21918a

2.66633b

0.37359

0.008451

1.00000

a

-1.31851

b

-1.11101

a

1.06292

a

0.07942

0.001029

a,b

-1.04902

b

a

1.07428

a

0.03587

0.005384

1.20419a

0.10765

0.004477

1.65795

b

0.15039

0.004848

1.22793

b

0.10040

0.008681

1.20792

b

0.05900

0.002913

1.12569a,b

1.25095b

0.05992

0.003096

-1.03225

a

b

0.03261

0.007426

-1.07103

a,b

-1.00782

0.03735

0.003804

-1.06766

a,b

a

Cluster 8
12915559
12870473

NPY1R

neuropeptide Y receptor Y1

12851703

TMEM168

transmembrane protein 168

1.00000

12677980

---Intron

---

1.00000a

12805856
12913565

LOC521580
---PLOD1

similar to histone cluster 1, H2bd
---

1.00000

a

1.00000

a,b
a

1.02972a

12899187

LOC100297846

similar to trace amine associated receptor 8

1.00000

12730199

LOC782645

similar to olfactory receptor Olr245

1.00000a

12810320
12878036

ZNF236
THG1L

zinc finger protein 236
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae)

1.00000

a,b

1.00000

a
a

12708470

LOC782479

similar to ribosomal protein L26

1.00000

12870694

SRP72

signal recognition particle 72kDa

1.00000a,b

12857895

PUS7L

pseudouridylate synthase 7 homolog (S. cerevisiae)

-1.26612b

1.00000

a

1.03429

a

1.07443

-1.11131a,b
1.04456

a

-1.16906

a

-1.07681

-1.03889

a

a

-1.06458

a

-1.14203

b

-1.21664

b

1.06342

a

1.05678

0.08608

0.009312

-1.02321a

-1.08373a

1.08183b

0.04071

0.006627

a

a

b

0.05312

0.000423

-1.10623

-1.09610

1.11736

a

1.13670

Table 1. (Continued)
12743540
12842784
12747334

GOLGA3
FCGR2
THOC5

golgi autoantigen, golgin subfamily a, 3
Fc fragment of IgG, low affinity IIb, receptor (CD32)
THO complex 5

1.00000a

-1.06641a,b

-1.08873b

1.08322a

0.03868

0.000934

1.00000

a

-1.13416

a,b

-1.27149

b

1.13919

a

0.08708

0.001204

1.00000

a

-1.08233

b

-1.03511

a,b

1.03841

a

0.03025

0.004399

a

-1.10483

b

-1.01514

a

1.06486

a

12809240

ADNP2

ADNP homeobox 2

1.00000

0.03198

0.000331

12844243

SNAPIN

SNAP-associated protein

1.00000a

-1.14259b

-1.19432b

-1.07056a,b

0.05038

0.007386

1.00000

a

-1.14634

b

-1.18867

b

-1.07987

a,b

0.04388

0.002467

1.00000

a

-1.07579

b

-1.11190

b

-1.01875

a,b

0.02836

0.002180

a

-1.18778

a,b

-1.40734

b

a

0.11243

0.002185

-1.11548b

1.05989a

0.04569

0.003257

-1.06740

a

b

-1.19484

b

-1.38906

b

12828917
12690686

ZNF22
ACIN1

zinc finger protein 22 (KOX 15)
apoptotic chromatin condensation inducer 1

12913489

ACLA_046210

DnaJ domain protein

1.00000

12840769

LEPRE1

leucine proline-enriched proteoglycan (leprecan) 1

1.00000a

12677698
12912371

---Intron
GCLC

--glutamate-cysteine ligase, catalytic subunit

1.00000

a

1.00000

a
a

12913085

CEP350

centromere-associated protein 350

1.00000

12708824

MIR2300B

microRNA mir-2300b

1.00000a

1

-1.08090a,b
-1.12940

a

-1.24385

b

-1.56052

b

-1.24583b

-1.32703b

1.12130

1.15727

0.06441

0.001365

-1.23431

b

0.06410

0.005740

-1.08920

a

0.10649

0.000839

-1.03539a

0.07937

0.001808
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Se supplement treatments that contained no Se (Control) or 3 mg Se/day in the form of sodium selenite (ISe), 1.5 mg Se/day of each

sodium selenite and SelPlex® mix (Mix), or 3 mg Se/day of SelPlex® (OSe) were top-dressed onto enough of a common cottonseed
hull/soybean hull/cracked corn-based diet (0.08 mg Se per day) to support 0.5 kg/day growth in maturing Angus-cross heifers for 168
days. The abundance of gene transcripts are reported relative to the mean expression of the Control group and are expressed as the foldchange of non-transformed data. 2Means with different superscripted letters differ (P < 0.05).
3

A missing symbol indicates a lack of confirmed bovine DNA or RNA sequence annotation.

4

The presented SEM values were pooled (averaged) from that of control (n = 9), ISe (n = 9), Mix (n = 9), and OSe (n = 9) treatment

groups.
5

P-values were obtained from one-way ANOVA F-test

Table 2. Hepatic miRNA (Mir), and their putative mRNA targets, that were
differentially expressed in response to dietary Se supplement. 1
MiR

Molecules in Network2

Top Functions3

ADCYAP1,DDHD1

Cell Morphology, Cell-To-Cell Signaling
and Interaction, Cellular Assembly and
Organization

ABCF3,ACIN1,AKR1C3,CASP2,CBX1,CBX3,CCNA1,CCND1,CDKN2
A,CLDN2,CTNNB1,DIABLO,GCM1,GOLGA3,GSK3B,HDAC1,HIC1,H
NF1A,HNF4A,HTRA2,LRRTM2,MFI2,NFYC,PPARA,QPCT,RBM39,RI
N2,RUFY3,SAP18,SENP1,SRPK2,SRR,TANK,TSNAX,ZNF236

Cell Cycle, Cancer, Neurological Disease

ADA,ADCYAP1,anandamide,Ca2+,CCL22,chemokine,CIB1,CXCL2,CXC
R2,Dsphingosine,DDHD1,ENTPD1,Eotaxin,FCGR2A,FKBP4,HOMER1,Integr
in alpha 4 beta 1,ITGA2,ITPR3,LAMA1,leukotriene B4,Lfa1,MOG,Plcbeta,PTAFR,Rap1,SELPLG,SFTPD,SLC9A3R1,TRP,TRPC3,
TRPC4,TRPC5,VIPR1,Vla-4
CRK,PCDHA2

Cell Signaling, Molecular Transport,
Vitamin and Mineral Metabolism

Mir-222

Mir-2393

E2F1,ZNF22
DLG4,FRAS1,GRIP1,GRIP2

Embryonic Development, Organ
Development, Organismal Development
Cancer, Cardiac Dysfunction, Cell Cycle
Developmental Disorder, Genetic Disorder,
Ophthalmic Disease
DNA Replication, Recombination, and
Repair, Gene Expression, Cellular
Assembly and Organization

ADNP2,CBX1,CBX3,NFYC

Mir-2300b
BCAR3,CCND1,CDK4,CSNK1A1,CSNK1D,CSNK1E,CTNNB1,DDR1,d
ihydrotestosterone,DYNC1I1,EBAG9,HADHB,HIST2H2BE,KAT7,KPN
A4,LRRTM2,MAPK14,NDC80,NGFR,NPY,PCM1,PKM2,RALY,RANB
P1,RCC1,RGS7,RUFY3,SNAPIN,TP53,TRPV1,Tubulin,UNC119,VRK1,
XPO1,ZFP106
ELMOD1,THG1L
DLG4,FRAS1,GRIP1,GRIP2
CTNNB1,dihydrotestosterone,SECISBP2,SEPW1

Cell Cycle, Cellular Assembly and
Organization, DNA Replication,
Recombination, and Repair

Tissue Morphology, Cellular Growth and
Proliferation, Cell Death
Developmental Disorder, Genetic Disorder,
Ophthalmic Disease
Organismal Injury and Abnormalities, Renal
Damage, Renal and Urological Disease

1

Differences in expression and dietary Se treatments are described in Table 1.

2

The mRNA for these proteins were differentially expressed by the liver in response

to supplemental Se treatment.
3

The top biofuctions are identified for the differentially expressed genes in the left.
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A

B
Figure 1. The correlation heat maps of 38 *. Cel files (A) before and 36 *.cel files (B)
after removing two outliers. The heat maps were generated based on the correlation
matrix (data are not shown). As indicated by the legend color box, gray color in the
middle represents the correlation coefficient value, 0.90, red color on the rightmost
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represents the highest correlation, and the blue color on the leftmost represents the
lowest correlation. The intensity of the color reflects the relative intensity of
correlation among chips. 8a indicates two chips are not correlated very well compared
to other chips. Their individual average correlation coefficients are 0.84 and 0.94.
After removing these two chips, 8b indicates the rest chips are correlated very well.
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Figure 2. Principle component analysis of microarray transcriptome analysis of day
168 liver samples at day 168 from Control (A/red), ISe (B/blue), Mix (C/green), and
OSe (D/purple) maturing Angus-cross heifers. The colored dots represent linear
combinations of the relative expression data, including expression values and
variances, of the 26,303 gene transcripts in each Bovine GeneChip. The center dot
(centroid) for each treatment groups represents the overall treatment expression
pattern.
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8

ISe
32
22

4
11

Mix
33

7

OSe
22

Figure 3. Zen diagram depiction of the relationship of 139 differentially expressed
gene transcripts by liver tissue of maturing Angus-cross heifers after 168 days of no
supplemental Se (Control) or 3 mg Se/day in the form of sodium selenite (ISe), 1.5
mg Se/day of each sodium selenite and SelPlex® mix (Mix), or 3 mg Se/day of
SelPlex® (OSe). Note that expression of eight transcripts differed among ISe, Mix, or
OSe treatments, but not versus Control heifers.
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Cluster 1
Cluster 2

Cluster 3

Cluster 4

Cluster 5

Cluster 6

Cluster 7

Cluster 8

Figure 4. Hierarchical cluster analysis of 139 differentially expressed (P < 0.01) gene
transcripts by liver tissue of maturing Angus-cross heifers after 168 days of no
supplemental Se (Trt A, red) or 3 mg Se/day sodium selenite (Trt B, blue), 1.5 mg
Se/day of each sodium selenite and SelPlex® mix (Trt C, green), or 3 mg Se/day in the
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form of SelPlex® (Trt D, purple), as indicated by the top color bar. The expression
level for each gene transcript was standardized to mean of 0 and scale to standard
deviation of 1, which is the default setting of the Partek Genomics Suite software. As
indicated by the bottom color bar, gray color in the middle represents the mean value,
0, red color represents gene expression levels above the mean expression whereas
blue color denotes expression below the mean. The intensity of the color reflects the
relative intensity level of transcript expression.
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0.100
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28
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Days on treatment

Fig. 5. Liver selenium (Se) concentrations (lsmeans with SEM as error bars) in
maturing beef heifers fed diets (224 days) supplemented with either no Se (Control)
or 3 mg Se/day in the form of sodium selenite (ISe), sodium selenite/SelPlex ® mix
(Mix) or SelPlex® (OSe). Treatment, days on treatment, and treatment x days on
treatment interaction effects (P ≤ 0.0001). Taken from Brennan et al.(2011).
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Figure 6. The pathway of different forms of Se metabolism. The whole figure shows the details of the pathway through which Se
obtained as dietary SeMet, SeCys, Selenate, and Selenite. After absorption and transport to the liver, they all are transformed to the
selenide intermediate that is incorporated into selenoproteins or excreted through methylation (Suzuki, 2005). The routs they come to
Selenide are different. Inorganic Se as Selenate and selenite must be reduced, either directly through the action of thioredoxin reductase
plus thioredoxin, or react with GSH to form GS-Se-SG, then form GS-SeH by the GSH reductase, then forms selenide. (Lu J et al., 2009).
In mammals, the selenate first be converted to selenite than participate the incorporation of selenoproteins. The conversion is catalyzed
by the bifunctional enzyme (fusion product of two catalytic activities) involved two steps: sulfate adenylyltransferase catalyzes the
formation of adenosine 5'-phosphosulfate (APS) from ATP and inorganic sulfate, then the APS is catalyzed by the adenylylsulfate kinase
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portion of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase to synthesize the selenite (Bandurski et al., 1956; Hilz and Lipmann,
1955; Venkatachalam et al., 1998). The selenite can also be converted back to selenic acid, the latter will be adenylylated to
adenylylselenate then phosphoralated to phosphoadenylylselenate catalyzed by the bifunctional enzyme phosphoadenosinephosphosulfate synthase (Lehninger, 2005; Salway, 2004). SeCys was through one step to be converted to selenide by the SeCys betalyase, with the production of Alanine (Ohta and Suzuki, 2008). Besides, the methyltransferases can transfer one-carbon groups to SeCys
to become methylSeCys, the later will be converted to gama-glutamyl-Se-methyl-SeCys, methyl-seleno-pyruvate, or methylselenol
(Kegg. 2011). SeMet uses two paths to go into the Selenide. The primary one is by transselenation to convert into SeCys like the Met
transfers to Cys (Suzuki, 2005), the intermediate Se-SAM was synthesized (Gammelgaard et al., 2011), this process is shown in the top.

The other one is by a gama-lyase catalyzed reaction to produce methylselenol, then by a demethylation process to produce selenide
(Suzuki, 2005). SeMet is also incorporated nonspecifically in place of Met into proteins, which is shown on the right top (review paper).
Once selenide is prepared, it is either used for synthesis of selenoproteins (on the left top of Figure) or as an intermediate metabolite for
Se excretion (on the bottom of Figure 6). Further steps in the assimilation of selenide into selenoproteins involve generation of
selenophosphate through the activity of selenophosphate synthetase (Tamura et al., 2004) and then incorporation of Selenophosphate into
selenocysteyl-tRNA[Ser][Sec] (Allmang et al., 2009). Se is excreted through the intermediate Selenide. At adequate level of intake it is
incorporated into selenosugar A and B for excretion in urine through the activity of methyltransferase and SAM (Kobayashi, et al., 2002).
At higher levels of intake the methyltransferase add the methyl group from SAM to convert selenide to methylselenol then
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dimethylselenide, then trimethylselonium, which is excreted in the urine (Ohta and Suzuki, 2008, Krittaphol, 2010). The methylselenol
can be reduced to methyl-selenic acid through a reversible reaction with the thioredoxin reductase (Moore et al., 1964; Speranza et al.,
1973; Arner and Holmgren, 2000)
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